Recurrent Pyogenic Cholangitis
Recurrent pyogenic cholangitis is a chronic biliary condition characterized by recurrent episodes of bacterial cholangitis associated with intrahepatic pigment stone formation and biliary strictures, predominantly affecting East Asian populations.
Recurrent Pyogenic Cholangitis (RPC) is a chronic biliary disease characterised by recurrent bouts of bacterial cholangitis arising from de novo formation of intrahepatic pigment stones within a biliary tree that is progressively damaged by stricturing and dilatation [1][2]. The name tells you everything:
- Recurrent = episodic, comes back again and again
- Pyogenic = "pyo" (pus) + "genic" (producing) — pus-forming bacterial infection
- Cholangitis = "chol" (bile) + "ang" (vessel) + "itis" (inflammation) — inflammation of the bile ducts
It is also historically known as "Hong Kong disease", oriental cholangiohepatitis, biliary obstruction syndrome of the Chinese, reflecting its strong geographic predilection for Southeast Asia [1][2].
Key Distinguishing Concept
RPC is fundamentally different from the more common Western pattern of gallstone disease. In typical gallstone disease, cholesterol stones form in the gallbladder and may migrate into the CBD. In RPC, brown pigment (calcium bilirubinate) stones form de novo within the intrahepatic bile ducts — the gallbladder is often a bystander. This distinction is critical for understanding the pathophysiology, clinical approach, and surgical management [1][2].
| Feature | Detail |
|---|---|
| Geographic distribution | Southeast Asia — Hong Kong, Southern China, Taiwan, Korea, Japan, Vietnam; rare in Western countries [1][2] |
| Sex ratio | Equal frequency in males and females [1] |
| Peak age | 30–40 years (middle-age onset) [1][2] |
| Socioeconomic association | Historically linked to lower socioeconomic status, poor sanitation, and dietary factors (raw freshwater fish consumption); incidence declining with improved hygiene but still prevalent in Hong Kong [2] |
| Trend | Decreasing incidence in younger generations due to improved nutrition, sanitation, and public health measures; however, established cases in older patients continue to present |
The disease earned the moniker "Hong Kong disease" because of its striking prevalence in Hong Kong and southern China. Any middle-aged patient from Southeast Asia presenting with recurrent cholangitis and intrahepatic stones should have RPC high on the differential.
Understanding the risk factors requires understanding the two "hits" needed for RPC: something that damages the biliary epithelium and something that promotes biliary stasis and stone formation.
| Risk Factor | Mechanism |
|---|---|
| Parasitic infestation (Clonorchis sinensis) | Flukes inhabit biliary tree → chronic epithelial damage → stricture formation → stasis → stone formation [1][2][3] |
| Low socioeconomic status / malnutrition | Low-protein diet → relative enzyme deficiency → altered bile composition → promotes unconjugated bilirubin precipitation [2] |
| Poor sanitation | Faecal-oral transmission of parasites; consumption of raw/undercooked freshwater fish [2][3] |
| Previous biliary instrumentation | ERCP, sphincterotomy, stenting → disruption of Sphincter of Oddi barrier → ascending bacterial colonisation [1] |
| Biliary anomalies | Choledochal cysts, Caroli's disease → congenital biliary stasis → predisposition to stone formation and infection [1] |
Anatomy and Function — The Biliary Tree
To understand RPC you must understand the biliary tree's anatomy and its normal defence mechanisms, because RPC systematically destroys both.
- Intrahepatic ducts: Small peripheral ducts → segmental ducts → sectoral ducts → right and left hepatic ducts
- Extrahepatic ducts: Common hepatic duct (CHD) → joined by cystic duct → common bile duct (CBD) → ampulla of Vater → duodenum
- Sphincter of Oddi: Muscular valve at the ampulla that controls bile flow into the duodenum and prevents duodenal reflux — this is critical for understanding ascending infection
The bile duct is NOT a sterile pipe — it has active defences:
- Continuous flushing action of bile flow — laminar flow physically washes bacteria downstream
- Bacteriostatic activity of bile salts — bile salts are detergents that disrupt bacterial cell membranes
- Biliary mucous and secretory IgA — act as anti-adherence factors preventing bacterial colonisation of epithelium
- Sphincter of Oddi — acts as a mechanical barrier to duodenal reflux and ascending bacterial infection
In RPC, all four mechanisms are compromised: strictures impede flow (loss of flushing), altered bile composition reduces bacteriostatic activity, chronic inflammation damages the mucosa (loss of IgA), and repeated instrumentation may disrupt the sphincter.
Why the Left Lobe?
RPC has a striking predilection for the left intrahepatic ducts [2]. Why? The left hepatic duct has a more acute angle of drainage and a longer intrahepatic course compared to the right. This anatomy promotes relative stasis in the left system, making it more susceptible to stone formation and stricturing. Additionally, the left duct is more prone to compression at the umbilical fissure. This is why, in advanced disease, left hepatic lobe atrophy is commonly seen on CT.
Etiology
1. Parasitic Infection (The Historical "First Hit")
Parasitic infestation is considered the initiating event in many cases of RPC, particularly in endemic areas [1][2][3].
| Parasite | Transmission | Pathological Mechanism |
|---|---|---|
| Clonorchis sinensis (Chinese liver fluke) | Consumption of raw or undercooked freshwater fish (淡水魚) [2][3] | Adult flukes inhabit biliary tract → mechanical damage to biliary epithelium → chronic inflammation → stricture formation → eggs deposited in bile ducts serve as nidus for stone formation |
| Opisthorchis viverrini | Raw freshwater fish (mainly Thailand/Laos) | Same mechanism as above |
| Fasciola hepatica | Contaminated watercress/water plants | Migrates through liver parenchyma → biliary tract inflammation |
Life cycle of Clonorchis sinensis (relevant for understanding pathogenesis) [3]:
- Humans = definitive host; adult flukes reside in biliary tract
- Embryonated eggs passed in faeces into freshwater
- Eggs ingested by freshwater snail (first intermediate host)
- Cercariae released → penetrate freshwater fish (second intermediate host) → encysted metacercariae in fish flesh
- Humans consume raw/undercooked fish → metacercariae excyst in duodenum → migrate up through ampulla of Vater into bile ducts → mature into adults
| Parasite | Mechanism |
|---|---|
| Ascaris lumbricoides | Adult worms can migrate into CBD through ampulla → mechanical obstruction → dead worm/eggs become nidus for stone formation |
Once biliary stasis and epithelial damage are established, bacterial colonisation drives the ongoing cycle of stone formation and recurrent cholangitis [1][2].
Common organisms:
| Category | Organisms |
|---|---|
| Gram-negative bacilli (predominant) | Escherichia coli, Klebsiella sp., Proteus sp., Pseudomonas aeruginosa [1] |
| Anaerobes | Bacteroides fragilis, Clostridium sp. [1] |
| Gram-positive | Enterococcus sp. |
Why gram-negatives? Because these are gut organisms. The infection is ascending — bacteria reflux from the duodenum into the biliary tree, especially when the sphincter of Oddi is compromised or when there is stasis.
Low-protein diet (historically prevalent in Southeast Asian populations) → relative deficiency of glucuronidase inhibitors → allows bacterial β-glucuronidase to act unopposed → promotes deconjugation of bilirubin → unconjugated bilirubin precipitates with calcium → brown pigment stone formation [2].
Pathophysiology
This is the crux of understanding RPC. The disease follows a self-perpetuating vicious cycle of Stasis + Stricturing + Recurrent infection [1][2].
Step 1 — Initiating Event: Epithelial Damage
- Parasitic infestation (Clonorchis sinensis) or bacterial infection damages the biliary epithelium
- The damaged epithelium triggers an inflammatory cascade
Step 2 — Stricture Formation
- Repeated cycles of inflammation → healing → fibrosis
- Fibrotic strictures develop, predominantly in the small intrahepatic ducts (small ducts are more affected than large ducts) [1]
- Strictures narrow the duct lumen → obstruction to bile flow
Step 3 — Biliary Stasis
- Bile cannot flow past the strictures efficiently
- Stagnant bile loses its normal flushing action → bacteria are not cleared
Step 4 — Bacterial Colonisation and Stone Formation
- Bacteria (especially E. coli, Klebsiella) produce the enzyme β-glucuronidase
- β-glucuronidase hydrolyses conjugated bilirubin (bilirubin diglucuronide) in bile back to unconjugated bilirubin
- Unconjugated bilirubin is insoluble and complexes with calcium ions → precipitation as calcium bilirubinate
- These aggregates, combined with bacterial cell bodies and cellular debris, form brown pigment stones
- Stones contain bacterial cell bodies embedded within them — this is why they are inherently infected stones
Step 5 — Further Obstruction and Recurrence
- Stones cause additional obstruction → more stasis → more infection → more stones → more strictures
- The cycle is self-perpetuating and progressive
Why Brown Pigment Stones, Not Cholesterol Stones?
In Western gallstone disease, the problem is cholesterol supersaturation in bile → cholesterol stones form in the gallbladder. In RPC, the problem is bacterial enzymatic deconjugation of bilirubin → calcium bilirubinate precipitates → brown pigment stones form de novo within the bile ducts. The stones are soft, earthy, crumbly (because they contain bacterial debris), in contrast to hard cholesterol stones. They are also radio-opaque (contain calcium) versus cholesterol stones which are radiolucent [2][4].
| Feature | RPC | Western Gallstone Disease |
|---|---|---|
| Stone location | Intrahepatic bile ducts (de novo) | Gallbladder (may migrate to CBD) |
| Stone type | Brown pigment / Ca bilirubinate | Cholesterol (85%) |
| Stone composition | Unconjugated bilirubin + calcium + bacterial debris | Cholesterol crystals |
| Pathogenic mechanism | Bacterial β-glucuronidase | Cholesterol supersaturation |
| Radiodensity | Radio-opaque | Radiolucent (80%) |
| Gallbladder involvement | Usually spared (gallbladder is a bystander) | Primary site |
| Biliary strictures | Present (part of the disease) | Not typical |
| Geographic distribution | Southeast Asia | Western countries |
| Sex predilection | Equal M:F | Female predominance (Fat, Female, Forty, Fertile) |
Classification
RPC can be classified by several schemes:
| Pattern | Description | Significance |
|---|---|---|
| Left-sided predominant | Stones and strictures mainly in left hepatic duct system | Most common pattern; left lobe atrophy frequently develops [2] |
| Right-sided predominant | Stones and strictures mainly in right hepatic duct system | Less common |
| Bilateral | Both left and right systems involved | More advanced disease; surgical options more limited |
| Extrahepatic involvement | CBD stones and strictures (often secondary) | May coexist with intrahepatic disease |
| Stage | Features |
|---|---|
| Early | Recurrent cholangitis episodes, intrahepatic stones, mild stricturing |
| Established | Multiple strictures, segmental/lobar atrophy, recurrent sepsis |
| Advanced / Complicated | Cirrhosis (secondary biliary), liver abscess, cholangiocarcinoma |
Clinical Features
The clinical presentation of RPC reflects the underlying cycle of biliary obstruction and infection.
- Middle-aged patient (30–40 years) from Southeast Asia
- Recurrent episodes of acute cholangitis — typically 1–2 episodes per year [2]
- Between episodes, patients may be relatively well
- Progressive deterioration over years with accumulating strictures, atrophy, and complications
| Symptom | Pathophysiological Basis |
|---|---|
| Fever (with or without chills and rigors) [1] | Bacterial infection of bile → endotoxin and bacterial products enter bloodstream → systemic inflammatory response (SIRS) → fever via IL-1, IL-6, TNF-α acting on hypothalamic thermoregulatory centre |
| Right upper quadrant (RUQ) or epigastric pain [1] | Biliary obstruction → ductal distension proximal to stone/stricture → stretching of the biliary epithelium and periductal tissues → visceral pain referred to the RUQ/epigastrium via T7-T9 splanchnic afferents. Unlike biliary colic (which is intermittent), RPC pain may be more sustained due to active infection |
| Jaundice [1] | Obstruction of bile ducts → impaired excretion of conjugated bilirubin → reflux into bloodstream → conjugated hyperbilirubinaemia → yellow sclera and skin. Degree depends on level and completeness of obstruction |
| Pruritus | Retained bile salts deposited in skin → stimulation of cutaneous nerve endings. More prominent with prolonged obstruction |
| Dark urine (tea-coloured) | Conjugated bilirubin is water-soluble → filtered by kidneys → bilirubinuria → dark urine |
| Pale/clay-coloured stools (acholic) | No bilirubin reaching the gut → no stercobilinogen production → pale stools |
| Malaise, anorexia, weight loss | Chronic infection, recurrent sepsis, and malabsorption of fat-soluble vitamins (A, D, E, K) due to impaired bile flow |
| Nausea and vomiting | Visceral irritation from biliary inflammation; may be exacerbated by associated pancreatitis |
| Sign | Pathophysiological Basis |
|---|---|
| Charcot's triad (Fever + RUQ pain + Jaundice) | The classic triad of acute cholangitis — present in majority of RPC flares. Fever = infection; pain = obstruction/distension; jaundice = biliary obstruction [1][2] |
| Reynold's pentad (Charcot's triad + shock + altered mental status) | Indicates suppurative cholangitis / biliary sepsis — bacteria and endotoxin overwhelm host defences → septic shock (hypotension) + encephalopathy. This is a surgical emergency < 10% of presentations [2] |
| RUQ tenderness | Periductal and hepatic capsular inflammation → localised tenderness on palpation |
| Hepatomegaly | Biliary obstruction → intrahepatic ductal dilatation → liver swelling; chronic disease → regenerative nodular hyperplasia |
| Palpable gallbladder (exception to Courvoisier's law) [4] | In RPC, the essential pathology is in the bile ducts, not the gallbladder. The gallbladder itself does not undergo chronic cholecystitis → it is NOT fibrosed → it CAN distend when the CBD is obstructed. This is why RPC is a classic exception to Courvoisier's law [1][4] |
| Jaundice (icterus) | Yellow discolouration of sclera (best detected in natural light) and skin; indicates bilirubin > 34 μmol/L (approximately 2 mg/dL) |
| Excoriations | Secondary to pruritus from bile salt deposition in skin |
| Signs of chronic liver disease (in advanced cases) | Spider naevi, palmar erythema, ascites, splenomegaly — develop if secondary biliary cirrhosis has occurred from chronic obstruction |
Courvoisier's Law and RPC — A Classic Exception
Courvoisier's Law states: "In painless obstructive jaundice, if the gallbladder is palpable, the cause is unlikely to be gallstones" [4]. The reasoning is that chronic gallstones → repeated cholecystitis → fibrosed, contracted gallbladder → cannot distend. In RPC, however: - The pathology is in the bile ducts (not gallbladder) - The gallbladder has NOT undergone chronic cholecystitis - Therefore the gallbladder CAN distend when the CBD is obstructed - RPC is one of three classic exceptions to Courvoisier's law: 1. Double impaction (stone in CBD + stone in cystic duct) 2. Mirizzi syndrome 3. Recurrent pyogenic cholangitis (RPC) [1][4]
| Category | Complications | Mechanism |
|---|---|---|
| Acute infectious | Biliary sepsis, liver abscess | Infected bile → bacteraemia → sepsis; walled-off intrahepatic infection |
| Pancreatitis | Acute biliary pancreatitis | Stone/sludge impaction at ampulla → pancreatic duct obstruction |
| Chronic structural | Secondary biliary cirrhosis, hepatic atrophy | Chronic obstruction → cholestasis → progressive fibrosis; chronic inflammation → parenchymal loss with compensatory atrophy [2] |
| Fistula | Biliary-enteric fistula | Chronic inflammation eroding through duct wall into adjacent bowel |
| Neoplastic | Cholangiocarcinoma | Chronic inflammation → dysplasia-carcinoma sequence; chronic biliary stasis → prolonged exposure to carcinogens in bile [1][2][3][5] |
The Cholangiocarcinoma Risk
RPC is a well-established risk factor for cholangiocarcinoma [3][5]. The mechanism is a chronic inflammation-driven dysplasia → carcinoma sequence — analogous to how ulcerative colitis predisposes to colorectal cancer. The association with cholangiocarcinoma is common in Orientals while PSC-associated cholangiocarcinoma is more common in Western populations [5]. Any patient with RPC who develops worsening obstructive symptoms, new weight loss, or rising CA 19-9 should be evaluated for superimposed malignancy.
Given its central role in RPC pathogenesis, Clonorchis sinensis deserves special attention [3]:
| Feature | Detail |
|---|---|
| Common name | Chinese liver fluke |
| Definitive host | Humans |
| First intermediate host | Freshwater snail |
| Second intermediate host | Freshwater fish |
| Transmission | Consumption of raw/undercooked freshwater fish (淡水魚) |
| Adult habitat | Biliary tract (intrahepatic bile ducts) |
| Eggs | Passed in faeces; embryonated |
| Clinical spectrum | Asymptomatic → acute cholangitis → RPC → increased risk of cholangiocarcinoma [3] |
| Diagnosis | Stool microscopy for eggs, duodenal aspirate for eggs, USG for adult flukes, intraoperative choledochoscopy for adult flukes [3] |
| Treatment | Praziquantel 25 mg/kg PO TDS × 1 day [3] |
Praziquantel works by increasing cell membrane permeability to calcium in the parasite → tetanic muscle contraction → paralysis and death of the fluke. It is the drug of choice for all trematode infections.
RPC remains highly relevant to clinical practice in Hong Kong:
- Historical burden: Hong Kong was historically one of the highest-prevalence areas, hence the name "Hong Kong disease"
- Current epidemiology: While incidence is declining due to improved sanitation and nutrition, established cases continue to present, particularly in older patients
- Dietary practices: Consumption of raw freshwater fish (sashimi, congee with raw fish) persists in some communities
- Association with cholangiocarcinoma — long-term surveillance is essential
- Surgical expertise: HKU and other Hong Kong centres have extensive experience in hepatobiliary surgery for RPC, including hepatic resection with biliary-enteric anastomosis
Key Concepts to Remember Before Moving to DDx/Diagnosis/Management:
- RPC = intrahepatic pigment stones + strictures + recurrent cholangitis
- Vicious cycle: stasis → infection → stone formation → more obstruction → more stasis
- Left lobe predilection
- Brown pigment stones (NOT cholesterol)
- Exception to Courvoisier's law
- Long-term risk of cholangiocarcinoma
- Clonorchis sinensis is the key parasitic trigger in Hong Kong
High Yield Summary
-
Definition: RPC = recurrent bacterial cholangitis + intrahepatic pigment stone formation + intrahepatic biliary strictures; also called "Hong Kong disease"
-
Epidemiology: Southeast Asia, equal M:F, peak 30–40 years
-
Pathophysiology — Vicious Cycle: Parasitic/bacterial damage → strictures → stasis → bacterial β-glucuronidase deconjugates bilirubin → Ca bilirubinate (brown pigment) stones → further obstruction → recurrent infection
-
Key Differences from Western Gallstone Disease: Stones form de novo in intrahepatic ducts (not gallbladder); composed of brown pigment (not cholesterol); radio-opaque (not radiolucent)
-
Left lobe predilection — due to anatomical factors promoting stasis
-
Clinical Features: Charcot's triad (fever + RUQ pain + jaundice); 1–2 episodes/year; Reynold's pentad if severe sepsis
-
Exception to Courvoisier's Law: Gallbladder NOT fibrosed (pathology is in ducts) → CAN distend
-
Clonorchis sinensis: Chinese liver fluke, transmitted by raw freshwater fish, initiates epithelial damage; treated with praziquantel
-
Major Long-term Complications: Secondary biliary cirrhosis, hepatic atrophy, cholangiocarcinoma
-
Organisms: E. coli, Klebsiella, Pseudomonas (gram-negatives); anaerobes; Enterococcus
Active Recall - Recurrent Pyogenic Cholangitis
[1] Senior notes: felixlai.md (Recurrent pyogenic cholangitis section, pp. 526–528) [2] Senior notes: maxim.md (Recurrent pyogenic cholangitis section, pp. 136–137) [3] Senior notes: maxim.md (Clonorchis sinensis infection section, p. 138) [4] Senior notes: felixlai.md (Courvoisier's law section, p. 568); maxim.md (Courvoisier's Law note, p. 130) [5] Lecture slides: WCS 064 - A large liver - by Prof R Poon [20191108].doc.pdf (p. 5, Cholangiocarcinoma — association with RPC in Orientals)
Differential Diagnosis of Recurrent Pyogenic Cholangitis
The clinical presentation of RPC — recurrent episodes of fever, RUQ pain, and jaundice (Charcot's triad) — is shared by a number of hepatobiliary conditions. The differential diagnosis should be approached systematically. Think of it this way: any condition that causes biliary obstruction + infection or biliary obstruction + inflammation can mimic RPC. The key is figuring out where the obstruction is, what is causing it, and whether the pattern is truly recurrent with intrahepatic stones [1][2][6].
The DDx of RPC is essentially the DDx of recurrent cholangitis and/or intrahepatic biliary disease. We can organise it by:
- Conditions presenting with Charcot's triad (fever + RUQ pain + jaundice)
- Conditions causing intrahepatic biliary strictures and stones (mimicking the imaging pattern of RPC)
- Conditions that are complications of or evolve from RPC itself
Detailed Differential Diagnosis
This is the single most important differential and the most common cause of acute cholangitis worldwide [6][7].
| Feature | Choledocholithiasis + Cholangitis | RPC |
|---|---|---|
| Stone origin | Gallbladder → migrates to CBD | De novo in intrahepatic ducts [1][2] |
| Stone type | Usually cholesterol (mixed) | Brown pigment (Ca bilirubinate) [1] |
| Gallbladder | Often contains stones; may be fibrosed from chronic cholecystitis | Usually spared; NOT fibrosed (exception to Courvoisier's law) [4] |
| Biliary strictures | Not a primary feature | Hallmark feature — intrahepatic strictures with dilatation [1][2] |
| Pattern | Usually single episode or few recurrences; resolves after cholecystectomy + CBD clearance | Recurrent (1–2 episodes/year); persists even after stone clearance because strictures reform [2] |
| Imaging | CBD dilatation ± CBD stone; gallstones in GB | Intrahepatic ductal dilatation with focal stricturing, left lobe predilection, ± hepatic atrophy [2] |
| Geography | Worldwide | Southeast Asia [1] |
Why this distinction matters: In choledocholithiasis, cholecystectomy + CBD clearance is usually curative. In RPC, the disease is in the intrahepatic ducts — simply removing CBD stones does NOT address the underlying strictures and intrahepatic stone burden. Missing RPC and treating it as simple choledocholithiasis leads to persistent recurrence [1][2].
How to Tell Them Apart
The key distinguishing features of RPC versus simple choledocholithiasis are: (1) intrahepatic stones (not just CBD), (2) intrahepatic strictures, (3) left lobe predilection, (4) pigment stones (not cholesterol), (5) recurrent pattern despite treatment, and (6) patient from Southeast Asia. If the imaging shows a clean gallbladder but intrahepatic ductal dilatation with strictures and stones — think RPC.
Liver abscess can present very similarly to RPC, and indeed liver abscess is also a complication of RPC — so they can coexist [8][2].
| Feature | Liver Abscess | RPC |
|---|---|---|
| Fever pattern | Swinging fever, chills and rigors, septic-looking [8] | Fever with or without chills; episodic pattern |
| Jaundice | Not significant (mainly parenchymal disease) [8] | Prominent (biliary obstruction) |
| Hepatomegaly | Tender hepatomegaly [8] | May have hepatomegaly but tenderness is RUQ-focused |
| Key imaging finding | USG: multiloculated cystic mass, no vascularity; CT: double-target sign (rim-enhancing with central hypodensity) [8] | USG/CT: dilated ducts with strictures and intrahepatic stones; atrophy |
| Blood culture | Often positive (Klebsiella, E. coli, Strep milleri) [8] | May be positive during acute episodes |
| Amoebic abscess | Bloody dysentery history; travel to endemic area; anchovy paste-like aspirate; no eosinophilia [8] | No dysentery |
| Biliary stones | Not a primary feature | Hallmark |
Why this is important: Liver abscess from RPC is caused by ascending biliary infection (20–30% of pyogenic liver abscess cases arise from biliary sources, including RPC, cholecystitis, and cholangitis) [8]. Always look for underlying RPC when you find a liver abscess in a Southeast Asian patient with intrahepatic duct abnormalities.
| Feature | Acute Cholecystitis | RPC |
|---|---|---|
| Pain | RUQ pain > 6 hours, positive Murphy's sign [9] | RUQ pain, but Murphy's sign typically negative (gallbladder not primarily inflamed) |
| Fever | Present | Present |
| Jaundice | Uncommon (unless Mirizzi syndrome or choledocholithiasis coexists) | Prominent |
| Imaging | USG: distended GB, GB wall thickening > 3mm, pericholecystic fluid, positive sonographic Murphy's sign [9] | USG: intrahepatic duct dilatation with stones and strictures; GB usually normal |
| Key distinction | Pathology is in the gallbladder | Pathology is in the intrahepatic bile ducts |
PSC and RPC can look remarkably similar on imaging — both cause biliary strictures and dilatation. However, they are fundamentally different diseases [6][10].
| Feature | PSC | RPC |
|---|---|---|
| Definition | Chronic progressive inflammation, fibrosis, and stricturing of bile ducts — large ducts more affected than small ducts [10] | Recurrent infection-driven stricturing — small intrahepatic ducts more affected [1] |
| Etiology | Autoimmune / unknown | Infectious (parasitic + bacterial) |
| Geographic predilection | Western countries (rare in Asia) [7][10] | Southeast Asia [1][2] |
| Associated conditions | Strong association with ulcerative colitis (majority of PSC patients have UC) [10] | Associated with parasitic infection (Clonorchis sinensis) |
| IBD association | Yes — ulcerative colitis [5][10] | No |
| Stone formation | Not a primary feature (but secondary stones can form) | Primary feature — de novo pigment stones |
| Cholangiogram appearance | "Beaded" appearance — diffuse multifocal strictures with intervening dilatation, both intrahepatic and extrahepatic | Intrahepatic strictures with left lobe predilection; central dilatation with peripheral tapering [2] |
| Serology | p-ANCA may be positive; ↑ IgG; ANA may be positive | Stool ova and parasites may be positive |
| Cancer risk | Cholangiocarcinoma (especially perihilar) [10] | Cholangiocarcinoma [2][5] |
Why distinguish them: Treatment is completely different. PSC has no proven medical therapy (ursodeoxycholic acid is controversial); management focuses on endoscopic treatment of dominant strictures and liver transplantation for end-stage disease. RPC management centres on stone clearance, biliary drainage, and hepatic resection [2][10].
PSC vs RPC — The Two Great Biliary Stricturing Diseases
A common exam pitfall is confusing PSC and RPC. Remember: PSC = Western, autoimmune, associated with UC, large ducts primarily affected, rare in Asia [7][10]. RPC = Oriental, infectious, associated with parasites, small intrahepatic ducts primarily affected, common in Hong Kong [1][2]. Both predispose to cholangiocarcinoma. PSC is listed as a cause of secondary sclerosing cholangitis when RPC causes similar-looking cholangiographic changes [10].
This is both a differential diagnosis of RPC and a complication of RPC — the two are intertwined [2][5][11].
| Feature | Cholangiocarcinoma | RPC |
|---|---|---|
| Presentation | Painless progressive obstructive jaundice in elderly ( > 50 years); RUQ pain, hepatomegaly, jaundice; anorexia, weight loss, fever [5][11] | Recurrent episodes of painful jaundice with fever in middle-aged patients |
| Pattern | Progressive, worsening | Episodic, recurrent |
| Risk factors | Association with UC (common in Westerners) and RPC (common in Orientals) [5]; PSC; choledochal cysts; Caroli's disease; thorium dioxide (Thorotrast) [11] | Parasitic infection, low socioeconomic status |
| Tumour markers | CEA and CA 19-9 may be elevated (but nonspecific) [5][11] | Not elevated (unless cholangiocarcinoma has developed) |
| Histology | > 90% adenocarcinoma; CK7 positive [11] | N/A (no neoplasm) |
| Key imaging distinction | Mass lesion, hilar obstruction (Klatskin tumour), vascular encasement | Stones + strictures without mass (unless superimposed cholangioCA) |
Clinical pearl: Any RPC patient with progressive worsening of jaundice, new weight loss, or rising CA 19-9 should be evaluated urgently for superimposed cholangiocarcinoma [2][5].
Cholangiocarcinoma: association with ulcerative colitis (common in Westerners) and recurrent pyogenic cholangitis (common in Orientals). Mostly occurs in patients > 50 years. [5]
| Feature | Mirizzi Syndrome | RPC |
|---|---|---|
| Definition | Common hepatic duct obstruction caused by extrinsic compression from an impacted stone in Hartmann's pouch/cystic duct [4][12] | Intrahepatic biliary strictures + stones from chronic infection |
| Jaundice | Present (CHD obstruction) | Present (intrahepatic obstruction) |
| Palpable GB | Jaundice with palpable GB — exception to Courvoisier's law [12] | Also exception to Courvoisier's law [4] |
| Imaging | USG: dilated biliary tree above stone impaction at GB neck; contracted GB [12] | USG: intrahepatic duct dilatation with stones and strictures |
| Cholecystobiliary fistula | Can develop (Csendes type 2–5) [12] | Not a feature |
| Key distinction | Pathology is at the cystic duct/Hartmann's pouch level; gallbladder is the culprit | Pathology is in the intrahepatic ducts; gallbladder is a bystander |
| Feature | Biliary Pancreatitis | RPC |
|---|---|---|
| Pain | Severe epigastric pain radiating to the back | RUQ/epigastric pain |
| Amylase/Lipase | Markedly elevated ( > 3× ULN) | Normal or mildly elevated |
| Jaundice | May be present (if stone at ampulla) | Present |
| Mechanism | Stone impacts at ampulla → pancreatic duct obstruction | Intrahepatic stones + strictures |
| Key distinction | Elevated pancreatic enzymes; pancreatic inflammation on CT | Intrahepatic ductal disease on imaging |
Note: Pancreatitis can also be a complication of RPC if stones/sludge migrate to the ampulla [2].
These congenital biliary anomalies can mimic RPC on imaging and also predispose to RPC [11][13].
| Feature | Caroli's Disease | Choledochal Cyst | RPC |
|---|---|---|---|
| Definition | Multiple cystic dilatations of intrahepatic bile ducts (Todani type V) [13] | Congenital cystic dilatation of intra/extrahepatic biliary system [13] | Acquired intrahepatic strictures + stones |
| Age at diagnosis | Usually childhood ( < 10 years in 60%) [13] | Usually childhood | Middle age (30–40 years) |
| Complications | Stone formation, cholangitis, cholangiocarcinoma [11][13] | Pancreatitis, cholangitis, cholangiocarcinoma [11][13] | Biliary sepsis, cirrhosis, cholangiocarcinoma |
| Imaging | Saccular intrahepatic duct dilatation ("central dot sign" on CT) | Extrahepatic cystic dilatation (type I most common) [13] | Strictures + dilatation + stones, left lobe predilection |
| Key distinction | Congenital; no strictures per se; saccular dilatation | Congenital; predominantly extrahepatic | Acquired; strictures are the hallmark |
| Feature | IgG4-Associated Cholangitis | RPC |
|---|---|---|
| Demographics | Mostly elderly male [7] | Equal sex, middle-age, Southeast Asian |
| Mechanism | Infiltration of biliary system with IgG4-positive plasma cells [7] | Infectious — parasitic + bacterial |
| Associated conditions | Autoimmune pancreatitis (type 1); may have multi-organ IgG4 disease | Parasitic infection |
| Serology | Elevated serum IgG4 | Normal IgG4; stool ova and parasites may be positive |
| Response to steroids | Dramatic response to corticosteroids | No response to steroids |
| Imaging | Diffuse or segmental bile duct wall thickening; can mimic cholangioCA | Strictures + dilatation + stones |
Post-operative biliary leaks (e.g., after cholecystectomy or liver surgery) can present with fever, abdominal pain, and jaundice, and should be considered in the post-surgical patient [6].
| Feature | Biliary Leak | RPC |
|---|---|---|
| Context | Post-operative | No surgical history required |
| Onset | Acute, days after surgery | Chronic, recurrent |
| Imaging | HIDA scan or MRCP showing biliary leak; biloma on CT/USG | Intrahepatic stones + strictures |
| Differential | Key Distinguishing Feature(s) from RPC |
|---|---|
| Choledocholithiasis + cholangitis | CBD stones from GB migration; cholesterol stones; no intrahepatic strictures; resolves after cholecystectomy |
| Liver abscess | Focal hepatic lesion; swinging fever; jaundice not prominent; double-target sign on CT |
| Acute cholecystitis | Murphy's sign positive; GB wall thickening; no intrahepatic duct disease |
| PSC | Western; autoimmune; UC association; large ducts; beaded cholangiogram; no stones primarily |
| Cholangiocarcinoma | Progressive painless jaundice; mass lesion; > 50 years; weight loss |
| Mirizzi syndrome | Stone impacted at Hartmann's pouch/cystic duct; CHD obstruction; cholecystobiliary fistula |
| Biliary pancreatitis | Markedly elevated amylase/lipase; pancreatic inflammation |
| Caroli's disease | Congenital; saccular intrahepatic dilatation; childhood presentation |
| Choledochal cyst | Congenital; predominantly extrahepatic cystic dilatation; childhood |
| IgG4-associated cholangitis | Elderly male; elevated IgG4; steroid-responsive; autoimmune pancreatitis |
| Biliary leak | Post-operative context; acute onset |
When you see biliary dilatation on imaging, the level of obstruction guides your differential [6]:
| Level | Differentials |
|---|---|
| Hilum | RPC, Klatskin tumour (cholangioCA), CA gallbladder, HCC (segments 4/5), Mirizzi syndrome, porta hepatis lymphadenopathy, PSC [6] |
| Mid-CBD | CA CBD, CA head of pancreas, lymphadenopathy [6] |
| Distal CBD | Bile duct strictures, periampullary carcinoma (duodenum, distal CBD, pancreatic head, ampulla of Vater), choledochal cysts, pancreatic cysts, chronic pancreatitis [6] |
RPC characteristically causes hilar and intrahepatic obstruction. If you see isolated distal CBD obstruction, think of other diagnoses first (periampullary tumour, choledocholithiasis, chronic pancreatitis).
When faced with a patient presenting with Charcot's triad, the following history points help narrow the differential [7]:
| Question | Purpose |
|---|---|
| Ethnicity / country of origin | Southeast Asian → RPC; Western → PSC, choledocholithiasis |
| Dietary history — raw freshwater fish? | Clonorchis sinensis exposure → RPC |
| Recurrence pattern — how many episodes? | Recurrent (1–2/year) → RPC; single episode → choledocholithiasis |
| Previous biliary surgery or ERCP | Post-procedural → biliary leak, stent occlusion, iatrogenic stricture |
| IBD history (bloody diarrhoea, UC) | PSC is strongly associated with UC [10] |
| Weight loss, progressive jaundice | Malignancy (cholangioCA, pancreatic CA) |
| Stool colour / urine colour | Tea-coloured urine + pale stool = obstructive jaundice (surgical cause) [7]; normal coloured = medical cause |
| Pain character | Colicky → stone; dull persistent → abscess/tumour; radiating to back → pancreatitis |
| Age | Middle-age → RPC; elderly with painless jaundice → malignant biliary obstruction until proven otherwise [7] |
Painless Progressive Obstructive Jaundice in the Elderly
Painless progressive obstructive jaundice in elderly is malignant biliary obstruction until proven otherwise [7]. This is a crucial clinical pearl. RPC typically presents with painful jaundice and fever in a middle-aged patient. If the jaundice is painless, progressive, and the patient is > 50, think cholangiocarcinoma, pancreatic head CA, or periampullary tumour first.
High Yield Summary — Differential Diagnosis
-
Most important DDx: Choledocholithiasis with acute cholangitis — differentiate by stone location (CBD vs intrahepatic), stone type (cholesterol vs pigment), presence of strictures, and recurrence pattern
-
Liver abscess can mimic AND complicate RPC — look for swinging fever, tender hepatomegaly, double-target sign on CT; jaundice is NOT prominent in isolated liver abscess
-
PSC vs RPC: PSC = Western, autoimmune, UC association, large duct disease, rare in Asia. RPC = Oriental, infectious, parasitic association, small duct disease, common in Hong Kong
-
Cholangiocarcinoma is both a DDx and a complication — progressive painless jaundice + weight loss in a patient > 50; associated with UC (Westerners) and RPC (Orientals)
-
Congenital causes (Caroli's disease, choledochal cysts) present in childhood; can predispose to RPC
-
Level of obstruction guides DDx: RPC causes hilar/intrahepatic obstruction; distal obstruction → think periampullary tumours
-
Exception to Courvoisier's law: Both RPC and Mirizzi syndrome are exceptions — but the mechanism differs (RPC: gallbladder not fibrosed because pathology is in ducts; Mirizzi: stone at Hartmann's pouch compresses CHD)
Active Recall - DDx of Recurrent Pyogenic Cholangitis
References
[1] Senior notes: felixlai.md (Recurrent pyogenic cholangitis section, pp. 526–527) [2] Senior notes: maxim.md (Recurrent pyogenic cholangitis section, pp. 136–137) [4] Senior notes: felixlai.md (Courvoisier's law section, p. 568); Senior notes: maxim.md (Courvoisier's Law note, p. 130) [5] Lecture slides: WCS 064 - A large liver - by Prof R Poon [20191108].doc.pdf (p. 5, Cholangiocarcinoma) [6] Senior notes: felixlai.md (Causes of biliary obstruction and level of obstruction, pp. 499–501) [7] Senior notes: maxim.md (Obstructive jaundice differential diagnosis, p. 135; Acute cholangitis section, pp. 135–136) [8] Senior notes: maxim.md (Liver abscess section, p. 125); Senior notes: felixlai.md (Liver abscess section, p. 436) [9] Senior notes: maxim.md (Symptomatic gallstones summary table, p. 130) [10] Senior notes: felixlai.md (Primary sclerosing cholangitis section, pp. 529–530) [11] Senior notes: felixlai.md (Cholangiocarcinoma etiology and pathogenesis, pp. 547–548); Senior notes: maxim.md (Cholangiocarcinoma risk factors, p. 139) [12] Senior notes: maxim.md (Mirizzi syndrome section, p. 132) [13] Senior notes: maxim.md (Choledochal cyst section, p. 138)
Diagnostic Criteria for Acute Cholangitis (Applied to RPC)
There is no standalone "diagnostic criteria" set for RPC per se — instead, the diagnosis of an acute RPC flare uses the diagnostic criteria for acute cholangitis (based on the Tokyo Guidelines, TG18/TG13), combined with imaging findings that are characteristic of the underlying RPC disease pattern. Think of it in two layers:
- Layer 1: Is this acute cholangitis? → Apply the Tokyo Guidelines criteria
- Layer 2: Is the underlying cause RPC? → Look for the characteristic imaging triad of intrahepatic stones + intrahepatic strictures + left lobe predilection
Tokyo Guidelines Diagnostic Criteria for Acute Cholangitis [6][7]
These criteria apply to any acute cholangitis episode, including those caused by RPC.
The patient must have BOTH of the following [6]:
| Criterion A (Systemic inflammation) | Criterion B (Cholestasis/biliary injury) |
|---|---|
| ONE of: Fever or shaking chills OR Laboratory evidence of inflammatory response (abnormal WBC, ↑ CRP, or other inflammatory markers) | ONE of: Jaundice OR Abnormal liver chemistries (↑ AST/ALT/ALP/GGT) |
In addition to meeting criteria for suspected diagnosis, the patient must have BOTH of the following [6]:
| Criterion C (Biliary dilatation) | Criterion D (Etiology identified) |
|---|---|
| Biliary dilatation on imaging | Evidence of an etiology on imaging: stone, stricture, or stent |
Applying TG18 to RPC
In RPC, the "definite diagnosis" criteria are almost always met during acute flares because imaging shows both biliary dilatation (from stricture-induced obstruction) and the etiology (intrahepatic stones and strictures). The challenge is not whether the patient has cholangitis — it's recognising that the underlying pattern is RPC rather than simple choledocholithiasis. This requires careful imaging interpretation.
| Grade | Criteria | Clinical Significance |
|---|---|---|
| Grade I (Mild) | Does not meet criteria for Grade II or III; responds to initial antibiotic therapy | Conservative management |
| Grade II (Moderate) | Any 2 of: WBC > 12 or < 4 ×10⁹/L, fever ≥ 39°C, age ≥ 75, bilirubin ≥ 85 μmol/L (5 mg/dL), albumin < 0.7× lower limit of normal | Early biliary drainage recommended |
| Grade III (Severe) | Organ dysfunction in any ONE system: cardiovascular (hypotension requiring vasopressors), neurological (altered consciousness), respiratory, renal (oliguria, Cr > 176 μmol/L), hepatic (PT-INR > 1.5), haematological (platelets < 100 ×10⁹/L) | Urgent biliary drainage — this is Reynold's pentad territory [6][7] |
Reynold's pentad (Charcot's triad + shock + altered mental status) corresponds to Grade III severity and requires emergent biliary drainage — delay leads to multiorgan failure and death [6][7].
Once acute cholangitis is confirmed, the following features on investigation point specifically to RPC rather than other causes [1][2]:
| Feature | Explanation |
|---|---|
| Intrahepatic stones (not just CBD stones) | Stones formed de novo within intrahepatic ducts — pathognomonic |
| Intrahepatic biliary strictures with proximal dilatation | Fibrotic narrowing from repeated infection-healing cycles |
| Central dilated bile ducts with peripheral tapering | Classic CT finding — central ducts dilated, peripheral ducts narrowed by strictures [2] |
| Left lobe predilection | Due to anatomical drainage angle promoting stasis [2] |
| Hepatic atrophy (usually left lobe) | Chronic obstruction and parenchymal destruction [2] |
| Absence of gallbladder stones (typically) | Stones form in ducts, not gallbladder — distinguishes from choledocholithiasis |
| Brown pigment stones (on ERCP/choledochoscopy) | Soft, earthy, calcium bilirubinate — not cholesterol |
| Recurrent history | 1–2 episodes per year over many years [2] |
| Southeast Asian ethnicity | Strong geographic predilection [1] |
Investigation Modalities — Detailed Breakdown
Before any bloods or imaging, the clinical examination itself provides crucial information:
| Finding | Significance | Pathophysiological Basis |
|---|---|---|
| Charcot's triad (fever + RUQ pain + jaundice) | Strongly suggests acute cholangitis [6] | Infection + obstruction + biliary backflow |
| Reynold's pentad (+ shock + confusion) | Grade III severity — needs urgent drainage [6][7] | Sepsis → endotoxaemia → cardiovascular collapse + encephalopathy |
| Palpable gallbladder | Exception to Courvoisier's law — suggests RPC (not chronic cholecystitis) [4] | Gallbladder not fibrosed (disease is in ducts) → can distend with CBD obstruction |
| Hepatomegaly | Intrahepatic ductal dilatation; may also indicate abscess | Biliary obstruction → back-pressure → liver swelling |
| Signs of chronic liver disease | Suggests secondary biliary cirrhosis (advanced RPC) | Chronic biliary obstruction → progressive fibrosis |
B. Laboratory Investigations
| Test | Expected Findings in RPC | Why This Test? (Pathophysiological Rationale) |
|---|---|---|
| CBC with differentials | Leukocytosis with neutrophil predominance [6][14] | Bacterial infection → bone marrow releases neutrophils → left shift. Thrombocytopenia if sepsis-associated DIC or hypersplenism from cirrhosis |
| CRP / ESR | ↑ ESR and CRP [6] | Acute phase reactants produced by the liver in response to IL-6; CRP useful for monitoring treatment response |
| LFT | ↑ ALP and GGT (cholestatic pattern); ↑ conjugated bilirubin; mild ↑ AST/ALT [6][14] | ALP and GGT are enzymes concentrated in the biliary epithelium — obstruction causes back-pressure and induction of these enzymes. Conjugated bilirubin rises because it is synthesised but cannot be excreted past the obstruction. AST/ALT may be mildly elevated from hepatocellular injury secondary to cholestasis |
| RFT | May show ↑ creatinine in severe cases | Renal impairment from sepsis (hepatorenal syndrome in cirrhotic patients) or direct nephrotoxicity from cholestasis |
| Clotting profile | Coagulopathy (prolonged PT/INR) [4][14] | Why? Bile cannot reach the intestine → cannot emulsify fats → cannot absorb fat-soluble vitamins (A, D, E, K) → Vitamin K is a co-factor for factors II, VII, IX, X → deficiency causes prolonged PT. This is critical to check before any invasive procedure like ERCP or PTBD |
| Blood culture (×2 sets BEFORE antibiotics) | May grow E. coli, Klebsiella, Enterococcus, Pseudomonas [7] | Blood culture is essential — guides targeted antibiotic therapy. Take before starting empirical antibiotics. Positive bile cultures are common with bile duct stones and other causes of obstruction [6] |
| Amylase / Lipase | Usually normal; elevated if concurrent pancreatitis | Rule out biliary pancreatitis (stone at ampulla → pancreatic duct obstruction) [7] |
| Stool for ova and parasites | May detect Clonorchis sinensis eggs [2][3] | Identifies the parasitic trigger — important for targeted treatment (praziquantel) and epidemiological understanding |
The Cholestatic Pattern — Explained from First Principles
Why ALP and GGT rise more than AST/ALT in biliary obstruction:
- ALP (alkaline phosphatase) is an enzyme found on the canalicular surface of hepatocytes (the bile duct-facing surface). When bile backs up, this membrane is disrupted → ALP leaks into blood. Additionally, bile acids that accumulate act as detergents that solubilise ALP from the membrane.
- GGT (gamma-glutamyl transferase) is concentrated in the biliary epithelium itself. Obstruction → epithelial damage → GGT release. GGT is also induced by bile acids.
- AST/ALT are cytoplasmic enzymes of hepatocytes — they rise primarily with hepatocellular damage (e.g., hepatitis). In cholestasis, the hepatocyte itself is not the primary target, so these rise only mildly from secondary back-pressure injury.
- Conjugated (direct) bilirubin rises because the hepatocyte conjugates bilirubin normally, but the conjugated product cannot be excreted through the obstructed ducts → refluxes back into the bloodstream → conjugated hyperbilirubinaemia.
| Finding | Significance |
|---|---|
| Bile in urine (conjugated bilirubin) | Conjugated bilirubin is water-soluble → filtered by kidneys when serum levels rise → bilirubinuria → dark "tea-coloured" urine. Confirms obstructive (post-hepatic) jaundice [6] |
| Absent urobilinogen | No bilirubin reaching the gut → no urobilinogen produced → none reabsorbed → absent in urine. Helps distinguish obstructive from hepatocellular jaundice |
C. Imaging Investigations
This is the cornerstone of RPC diagnosis. The goals of imaging are:
- Confirm biliary obstruction (dilatation)
- Identify the cause (stones, strictures)
- Map the extent of disease (which segments affected, atrophy)
- Detect complications (abscess, cholangiocarcinoma)
- Plan intervention (drainage route, surgical resection)
USG is the initial imaging modality for any patient with suspected biliary disease [1][2][7].
| Finding | Description | Significance |
|---|---|---|
| Dilated intrahepatic ducts | Parallel channel sign (dilated duct running alongside portal vein branches); intrahepatic ducts normally < 2–3 mm and not visible on USG [14] | Confirms biliary obstruction |
| Intrahepatic stones | Hyperechoic foci within dilated ducts ± posterior acoustic shadowing | Direct visualisation of RPC stones; brown pigment stones may be less echogenic than cholesterol stones |
| Liver abscess | Hypoechoic or complex cystic lesion within liver parenchyma | Complication of RPC — must rule out [1][2] |
| Gallbladder | Usually normal (no stones, no wall thickening) | Helps distinguish from cholecystitis/choledocholithiasis |
| CBD dilatation | CBD > 8 mm (or > 0.1 cm per decade of age) [14] | May be present if extrahepatic component exists |
Limitations of USG:
CT provides more anatomical detail than USG and is critical for surgical planning and complication detection [1][2].
| Finding | Description | Significance |
|---|---|---|
| Central dilated bile ducts with peripheral tapering | Dilated central intrahepatic ducts that narrow peripherally due to strictures | Classic CT finding of RPC [2] — the strictures are peripheral, so central ducts dilate while peripheral ducts are narrowed |
| Left lobe predilection | Disease predominantly affecting left hepatic lobe | Characteristic of RPC [2] |
| Hepatic atrophy (usually left lobe) | Volume loss of the affected hepatic lobe | Chronic obstruction → parenchymal destruction → atrophy with compensatory hypertrophy of the contralateral lobe [1][2] |
| Intrahepatic calculi | Hyperdense foci within dilated ducts | Brown pigment stones are radio-opaque (contain calcium) |
| Liver abscess | Rim-enhancing hypodense lesion (double-target sign) [8] | Complication |
| Suspicious mass | Irregular enhancing mass within or adjacent to strictured duct | Raises concern for superimposed cholangiocarcinoma [5] |
Why CT is important in RPC specifically: CT demonstrates whether disease is localised (usually to the left lobe) and whether atrophy has developed [1] — both critical factors in deciding whether hepatic resection is indicated.
MRCP is a non-contrast, T2-weighted MRI sequence that provides exquisite detail of the biliary tree without any invasive intervention [14].
| Feature | Detail |
|---|---|
| Technique | Non-contrast, T2-weighted — bile appears bright (hyperintense) because it is fluid [14] |
| Advantages | Non-invasive; permits detailed visualisation of extent of biliary involvement which may not be possible by ERCP when there are extensively occluded segments [1]; no radiation; no contrast needed |
| Limitations | Does NOT permit therapeutic interventions [1] — purely diagnostic |
| Key findings in RPC | Intrahepatic duct dilatation and strictures; stone burden mapping; extent of disease (unilateral vs bilateral); biliary anatomy before surgery |
| When to use | When USG is equivocal but clinical suspicion remains high; for preoperative biliary mapping; when ERCP cannot access occluded segments [1][6] |
MRCP vs ERCP — Understanding the Trade-off
MRCP has largely replaced ERCP as a diagnostic tool [14]. ERCP carries procedural risks (pancreatitis, perforation, bacteraemia), so it should be reserved for when therapeutic intervention is planned. MRCP gives you the anatomy for free — use it first for mapping, then deploy ERCP when you need to drain, stent, or extract stones.
ERCP is both diagnostic and therapeutic and is the first-line intervention for acute biliary drainage [1][6][7].
| Feature | Detail |
|---|---|
| Technique | Endoscope advanced to duodenum → cannulation of ampulla of Vater → contrast injection → fluoroscopic visualisation of biliary tree |
| Diagnostic role | Confirm diagnosis; show level and cause of obstruction; delineate biliary anatomy [6] |
| Therapeutic role | Biliary drainage and decompression (the primary goal in acute setting); sphincterotomy; stricture balloon dilatation; stone extraction; stent placement [1][7] |
| Key RPC-specific finding | Multiple intrahepatic and extrahepatic stones; strictures; soft brown pigment stones |
| Prophylactic antibiotics required | Due to risk of inciting cholangitis or sepsis following manipulation of bile ducts [1] |
| Bile culture | Can aspirate bile during ERCP for culture and sensitivity — guides antibiotic therapy [6] |
Challenges of ERCP in RPC [1]:
- Endoscopic intervention is challenging due to multiple intrahepatic and extrahepatic stones as well as stricturing [1]
- ERCP accesses the biliary tree from below (retrograde) — it is inherently limited in reaching intrahepatic ducts, especially those above tight strictures
- ERCP difficult to access intrahepatic drainage [2] — this is why PTBD is often needed
ERCP procedure in acute cholangitis [7]:
- Aspirate bile duct to remove bile and pus → decompress biliary tree → reduces risk of bacteraemia during contrast injection
- Then inject contrast and visualise anatomy
- Place plastic stent (temporary, requires scheduled change) with or without sphincterotomy
- Stone removal can be done now or deferred (interval ERCP after sepsis resolves)
Role of ERCP in unstable patients is biliary drainage and decompression — NOT stone removal [7]. The priority is to relieve obstruction and control sepsis. Definitive stone clearance comes later.
PTBD is preferred to ERCP when the obstruction is at or above the level of confluence of hepatic ducts — which is often the case in RPC [14].
| Feature | Detail |
|---|---|
| Technique | Percutaneous needle inserted through the liver parenchyma into a dilated intrahepatic duct → contrast injection for cholangiography → guidewire → catheter placement for drainage |
| Diagnostic role | Visualisation of biliary tree above the obstruction (where ERCP cannot reach) [14] |
| Therapeutic role | Bile drainage by catheter (PTBD) or insertion of indwelling stents [14] |
| When preferred over ERCP | Stricture/obstruction at or above the level of confluence of hepatic ducts [14]; ERCP unsuccessful or contraindicated; examples include cholangiocarcinoma, PSC, RPC [14] |
| Advantage over ERCP for RPC | Transhepatic insertion of intrahepatic bile duct (directly accesses the intrahepatic disease, not limited by retrograde access) [7]; easy output monitoring (external drainage) [7] |
| Complications | Bacteraemia (thus antibiotic prophylaxis required) [14]; haemobilia; bile leak; pneumothorax (if right-sided approach) |
| Disadvantage | Risk of fluid and electrolyte loss (external drainage) [7]; patient discomfort from external catheter |
| Feature | Detail |
|---|---|
| Technique | Direct endoscopic visualisation of bile duct lumen — either during surgery (intraoperative choledochoscopy) or percutaneously through a mature PTBD tract |
| Role in RPC | Direct visualisation and removal of intrahepatic stones; inspection for strictures; detection of adult Clonorchis sinensis flukes [3]; biopsy of suspicious lesions (r/o cholangiocarcinoma) |
| Advantage | Can reach intrahepatic ducts that ERCP and PTBD cannot; allows direct stone fragmentation and extraction |
| Feature | Detail |
|---|---|
| Role | Useful adjunct for choledocholithiasis detection; staging periampullary and pancreatic cancers [14]; therapeutic EUS (EUS-guided cholangiopancreatography) as alternative drainage when ERCP fails [7] |
| Limitation in RPC | Less useful for mapping intrahepatic disease specifically; better for extrahepatic and periampullary pathology |
| Modality | Role |
|---|---|
| Erect CXR | Aerobilia (air in biliary tree — suggests prior sphincterotomy or biliary-enteric fistula); right basal effusion/collapse (if liver abscess present) [7] |
| AXR (Abdominal X-ray) | Radio-opaque calculi in RUQ (brown pigment stones contain calcium → may be visible); aerobilia [7] |
| MRI liver with contrast | Liver-specific contrast (e.g., Primovist/gadoxetic acid) — superior to CT in detecting small hepatocellular lesions; useful if cholangiocarcinoma suspected |
| Modality | Pros | Cons | When to Use |
|---|---|---|---|
| USG | Non-invasive, bedside, cheap, no radiation, first-line | Operator-dependent; misses distal CBD; misses small stones | Always first |
| CT | Anatomical detail; detects atrophy, abscess, mass; staging | Radiation; IV contrast needed; less biliary detail than MRCP | Surgical planning; r/o complications |
| MRCP | Best non-invasive biliary mapping; no contrast/radiation | Not therapeutic; cannot intervene | Biliary anatomy mapping; pre-op planning |
| ERCP | Diagnostic AND therapeutic; gold standard for drainage | Invasive; risks (pancreatitis, perforation, sepsis); limited intrahepatic access | Acute drainage; stone removal |
| PTBD | Directly accesses intrahepatic ducts; external drainage | Invasive; bacteraemia risk; fluid/electrolyte loss | When ERCP fails or obstruction at/above confluence |
| Choledochoscopy | Direct visualisation; stone removal; biopsy capability | Requires mature tract or surgical access | Intraoperative; complex stone disease |
| EUS | Good for CBD/periampullary; therapeutic alternative | Limited intrahepatic reach | Adjunct; ERCP failure |
The Queen Mary Hospital (HKU-affiliated) approach to biliary drainage in cholangitis follows this stepwise escalation:
QMH practice: ERCP → PTBD → ECBD [6]
- ERCP — first attempt at biliary decompression
- PTBD — if ERCP fails (e.g., cannot access intrahepatic ducts through strictures) or contraindicated
- ECBD (Exploration of CBD) — surgical exploration with T-tube placement if both ERCP and PTBD fail; high mortality (~30%) [7] — reserved as last resort
When you see a patient with suspected RPC, here is the complete workup:
Immediate (Acute presentation):
- Blood culture ×2 (BEFORE antibiotics) [7]
- CBC D/C, CRP
- LFT (ALP, GGT, bilirubin, AST, ALT)
- RFT
- Clotting profile (PT/INR)
- Amylase (r/o pancreatitis)
- USG abdomen (first-line imaging) [1][2]
- Erect CXR (r/o perforation, right basal pathology) [7]
After initial stabilisation:
- Stool for ova and parasites [2]
- CT abdomen with contrast (if surgical planning needed or suspecting complications) [1][2]
- MRCP (biliary mapping, especially if ERCP cannot visualise occluded segments) [1]
For therapeutic intervention / acute drainage:
- ERCP (first-line for drainage; prophylactic antibiotics required) [1][6]
- PTBD (if ERCP fails or obstruction above confluence) [7][14]
For suspected superimposed malignancy:
- CEA and CA 19-9 (nonspecific; serial monitoring more useful) [5][14]
- CT/MRI for mass characterisation
- FNAC or Trucut biopsy (ONLY for unresectable cases) [5]
- Choledochoscopy with biopsy
For long-term surveillance:
- Regular USG surveillance [2]
- Serial tumour markers if cholangiocarcinoma risk is high
High Yield Summary — Diagnosis of RPC
-
Diagnostic criteria: Use Tokyo Guidelines (TG18) for acute cholangitis — Suspected: systemic inflammation + cholestasis; Definite: + biliary dilatation + etiology on imaging
-
Severity grading matters: Grade III (organ dysfunction / Reynold's pentad) → urgent biliary drainage
-
RPC-specific imaging pattern: Intrahepatic stones + strictures + central dilatation with peripheral tapering + left lobe predilection + hepatic atrophy
-
Blood tests: Cholestatic pattern LFT (↑ ALP, GGT, conjugated bilirubin); leukocytosis; blood culture BEFORE antibiotics; clotting (Vitamin K deficiency); stool ova and parasites
-
Imaging hierarchy: USG first → CT for staging/complications → MRCP for biliary mapping → ERCP for therapeutic drainage
-
MRCP does NOT permit therapeutic interventions — use it for mapping, not treatment
-
ERCP prophylactic antibiotics required due to risk of inciting cholangitis
-
PTBD preferred over ERCP when obstruction at or above hepatic duct confluence — directly accesses intrahepatic disease
-
QMH practice: ERCP → PTBD → ECBD (stepwise escalation)
-
Tumour markers (CEA, CA 19-9) are NOT useful for screening — absence does not exclude malignancy; useful for serial monitoring post-resection
Active Recall - Diagnosis of RPC
[1] Senior notes: felixlai.md (Recurrent pyogenic cholangitis — Diagnosis section, pp. 526–528) [2] Senior notes: maxim.md (Recurrent pyogenic cholangitis section, pp. 136–137) [3] Senior notes: maxim.md (Clonorchis sinensis infection section, p. 138) [4] Senior notes: felixlai.md (Courvoisier's law section, p. 568); Senior notes: maxim.md (Courvoisier's Law note, p. 130) [5] Lecture slides: WCS 064 - A large liver - by Prof R Poon [20191108].doc.pdf (p. 5, Cholangiocarcinoma diagnosis — tumour markers, USG, CT, MRI, FNAC) [6] Senior notes: felixlai.md (Acute cholangitis — Diagnosis and Treatment, pp. 520–523) [7] Senior notes: maxim.md (Acute cholangitis — Investigations and acute management, pp. 135–136) [8] Senior notes: maxim.md (Liver abscess section, p. 125) [14] Senior notes: felixlai.md (MBO — Biochemical and Radiological tests, pp. 502–503); Senior notes: maxim.md (HBP investigations, pp. 121–122)
The management of RPC must be understood in two distinct phases, because the disease has two faces:
- Acute phase: Treat the cholangitis flare — this is an emergency
- Long-term phase: Break the vicious cycle of stasis → infection → stones → strictures → more stasis — this requires definitive intervention
The fundamental principle is that you cannot cure RPC with antibiotics alone. Why? Because the underlying problem is mechanical — strictures and stones cause obstruction and stasis, and antibiotics cannot clear stones or open strictures. Furthermore, excretion of antibiotics is impaired in biliary obstruction [15][16] — the very antibiotics you give cannot reach therapeutic concentrations in the obstructed bile, making biliary drainage mandatory [16].
Phase 1: Acute Management — "RAD"
The mnemonic RAD captures the three pillars of acute cholangitis management [7]:
R = Resuscitation, A = Antibiotics, D = Drainage — must know! [7]
| Component | Detail | Rationale |
|---|---|---|
| NPO (Nil per os) | Keep patient fasting | Reduces biliary stimulation (CCK release → gallbladder contraction → increased biliary pressure); prepares for potential emergency ERCP |
| IV fluids | Aggressive crystalloid resuscitation (e.g., Ringer's lactate / normal saline) | Biliary sepsis → vasodilatation + third-spacing → intravascular volume depletion → organ hypoperfusion. Fluids restore circulating volume |
| Monitor vitals and I/O Q1h [7] | Continuous monitoring of temperature, pulse, BP, consciousness level, urine output [6] | Detects signs of failure of conservative treatment: ↑ temperature/pulse, ↓ BP/consciousness/urine output, increased abdominal tenderness and guarding [6] |
| Correct coagulopathy | IV Vitamin K (phytomenadione 10 mg slow IV) | Obstructive jaundice → impaired fat-soluble vitamin absorption → Vitamin K deficiency → coagulopathy. Must correct before any invasive procedure |
Why Monitor So Closely?
15% of patients will NOT respond to antibiotics and will require emergency biliary decompression [6]. You need to catch this deterioration early. The signs of failure include rising temperature, tachycardia, falling BP, falling urine output, worsening tenderness, and altered consciousness — essentially progression towards Reynold's pentad.
2. Antibiotics
The empirical regimen must cover the organisms that cause RPC cholangitis: Gram-negative aerobes (E. coli, Klebsiella, Pseudomonas) and anaerobes (Bacteroides) [1][6].
Why not just one antibiotic? Because the bile duct in RPC harbours a polymicrobial environment, and inadequate coverage leads to treatment failure and fulminant sepsis.
| Regimen | Coverage | When to Use |
|---|---|---|
| IV Cefuroxime + Metronidazole [15] | Cefuroxime: Gram-negative aerobes; Metronidazole: anaerobes | Standard HK regimen for mild–moderate disease |
| IV Piperacillin-Tazobactam (Tazocin) [7][15] | Broad-spectrum: Gram-negatives including Pseudomonas + anaerobes | Severe disease or Reynold's pentad |
| IV Ampicillin-Sulbactam (Augmentin) | Gram-negatives + anaerobes | Mild disease [7] |
| IV Metronidazole + 3rd-gen cephalosporin (e.g., Ceftriaxone) [6] | Ceftriaxone: Gram-negatives; Metronidazole: anaerobes | Alternative regimen |
| IV Metronidazole + Fluoroquinolone (e.g., Ciprofloxacin/Levofloxacin) [6] | Fluoroquinolone: Gram-negatives; Metronidazole: anaerobes | Penicillin allergy |
Duration: Typically 7 days of IV antibiotics [7], then step down to oral based on culture and sensitivity results.
Why Antibiotics Alone Are Not Enough
Biliary obstruction impairs the excretion of antibiotics into bile [16]. Normal biliary pressure is 7–14 cm H₂O. When pressure rises > 25 cm H₂O (due to obstruction), bacteria reflux into hepatic veins and lymphatics → bacteraemia and septic shock [16]. Even high-dose IV antibiotics cannot achieve adequate biliary concentrations when the duct is obstructed. This is why biliary drainage is mandatory [16] — you must physically decompress the system.
- Adjust based on blood/bile culture and sensitivity results
- If Clonorchis sinensis identified on stool O&P: add praziquantel 25 mg/kg PO TDS × 1 day [3]
3. Drainage — The Critical Step
Biliary drainage is the definitive acute intervention — it addresses the mechanical obstruction that antibiotics cannot fix [16].
- Reynold's pentad (Charcot's triad + shock + altered mental status)
- Not responding to antibiotics for 24 hours [7]
- Why 24 hours? Because obstruction impairs antibiotic secretion into bile — if there's no improvement in 24h, it means the obstruction is not resolving spontaneously and drainage is mandatory
3A. ERCP — First-Line Drainage
ERCP is the first-line approach for biliary drainage in acute cholangitis [6][7][15].
| Aspect | Detail |
|---|---|
| Procedure | Endoscope to D2 → cannulate ampulla → aspirate bile/pus → inject contrast → visualise obstruction → intervene |
| Role in acute setting | Biliary drainage and decompression in unstable patients — NOT stone removal [7] |
| Step 1 | Aspirate bile duct to remove bile and pus → decompress → reduces risk of bacteraemia during contrast injection [7] |
| Step 2 | Inject contrast → delineate anatomy |
| Step 3 | Place plastic stent (temporary, requires scheduled change) with or without sphincterotomy [7] |
| Step 4 | Remove stone now or interval ERCP after sepsis resolves [7] |
| Mortality | < 5% [7] |
a) Endoscopic Sphincterotomy [6]
- What: Electrocautery incision through the musculature of the biliary portion of the Sphincter of Oddi
- Why: Eliminates the principal anatomic barrier impeding stone passage; facilitates stone extraction; allows future access
- Complications:
- Short-term: Acute pancreatitis, perforation (intraperitoneal or retroperitoneal), bleeding from papillotomy, infection [6][15]
- Intraperitoneal perforation: Perforate the duodenum → free gas under diaphragm on CXR → requires operative treatment (will not seal spontaneously) [6]
- Retroperitoneal perforation: Perforate the bile duct when cutting the ampulla (retroperitoneal portion of D2) → no free gas under diaphragm → retroperitoneal gas may be present → conservative treatment (will seal spontaneously) [6]
- Long-term: Acute cholangitis recurrence, stone recurrence, papillary stenosis [6]
- Short-term: Acute pancreatitis, perforation (intraperitoneal or retroperitoneal), bleeding from papillotomy, infection [6][15]
b) Stricture Balloon Dilatation [1]
- Balloon inflated across stricture to widen the lumen
- Important in RPC because strictures are the primary mechanical problem
c) Biliary Stent Placement [1]
- Plastic stent (temporary) — requires scheduled exchange (every 3 months typically, as plastic stents occlude with biofilm/sludge)
- Purpose: maintains biliary drainage through the strictured segment
- Initial biliary decompression is achieved by ERCP with sphincterotomy, stricture dilatation and placement of biliary endoprosthesis (stent) often required [1]
d) Stone Extraction Methods [15]
| Method | Description |
|---|---|
| Wire basket (Dormia basket) | Wire cage deployed around stone → trapped → extracted through sphincterotomy |
| Stone extraction balloon | Balloon inflated above stone → swept downward through sphincterotomy |
| Mechanical lithotripsy | For large stones → mechanical crushing within the duct |
Endoscopic intervention is challenging due to multiple intrahepatic and extrahepatic stones as well as stricturing [1]. Key issues:
- ERCP accesses from below (retrograde) → limited access to intrahepatic ducts above tight strictures
- ERCP difficult to access intrahepatic drainage [2] — the disease in RPC is predominantly intrahepatic
- Multiple strictures may prevent passage of the scope or instruments
- Patients in whom adequate drainage cannot be achieved during ERCP will require percutaneous or surgical drainage [1]
Altered GI anatomy e.g. Billroth II gastrectomy, Roux-en-Y [15] — the altered anatomy makes cannulation of the ampulla technically very difficult or impossible.
PTBD is indicated when ERCP is unsuccessful, unavailable, or contraindicated [6][7].
| Aspect | Detail |
|---|---|
| Technique | Percutaneous needle through liver parenchyma → puncture dilated intrahepatic duct under USG/fluoroscopic guidance → confirm position with contrast → insert guidewire → catheter placement [6] |
| Access route | Usually via left hepatic duct (preferred — subcostal approach is less painful than intercostal for right duct; less likely to transgress pleural space) or right hepatic duct; can also access through gallbladder puncture [6] |
| Key advantage for RPC | Transhepatic insertion directly into intrahepatic bile ducts — directly accesses the intrahepatic disease that ERCP cannot reach [7] |
| Therapeutic capabilities | Drainage of infected bile; extraction of biliary stones; dilatation of benign strictures; stent placement across strictures [6] |
| Efficacy | Similar efficacy and rate of complications as ERCP [7] |
| Output monitoring | Easy output monitoring — external drainage [7], but can be internalised later (external-internal PTBD) |
| Complications | Bacteraemia (antibiotic prophylaxis required); haemobilia (puncture of hepatic artery or portal vein); bile leak; pneumothorax [6][14] |
| Disadvantages | Risk of fluid and electrolyte loss (external bile drainage) [7]; patient discomfort from external catheter; requires patent intrahepatic duct dilatation for safe access |
The reason PTBD is particularly useful in RPC compared to simple choledocholithiasis is that the disease is in the intrahepatic ducts, and PTBD goes directly to the problem. ERCP approaches from below and is limited by strictures blocking retrograde access.
Surgical drainage for acute cholangitis is reserved for patients in whom other methods of biliary drainage cannot be performed or have failed [6].
| Procedure | Detail |
|---|---|
| Exploration of Common Bile Duct (ECBD) | Open (emergency) or laparoscopic (selected elective cases) → choledochotomy → stone removal → T-tube placement for ongoing drainage and future cholangiography [6][15] |
| Indications | Failure of endoscopic drainage; deterioration despite endoscopic drainage [15] |
| T-tube | Placed in CBD after exploration → provides ongoing bile drainage → allows subsequent cholangiogram to check for residual stones |
| Mortality | ~30% [7] — this is why surgery is the last resort for acute cholangitis |
| Approach | Open approach for emergency case; laparoscopic approach in selected elective case [15] |
Why Is Surgical Drainage So Dangerous?
The high mortality (~30%) of surgical CBD exploration in acute cholangitis [7] is because these patients are already septic, often with organ dysfunction (Grade III severity). General anaesthesia in a septic patient compounds haemodynamic instability. The combination of sepsis + surgical stress + coagulopathy (Vitamin K deficiency from obstruction) + impaired wound healing (from cholestasis-related protein synthesis impairment) makes operative mortality very high. This is why the stepwise escalation ERCP → PTBD → surgery is so important — exhaust less invasive options first.
| Modality | Role |
|---|---|
| T-tube drainage | Can be placed during ECBD or through a mature PTBD tract; allows ongoing external drainage and access for cholangiography [2] |
| Hepaticocutaneojejunostomy (HCJ) | A surgical technique creating a conduit from intrahepatic bile ducts through a Roux-en-Y jejunal loop to the skin surface — allows future percutaneous access for repeat stone clearance without needing ERCP [2]. Used in complex RPC with recurrent stone formation |
| Therapeutic EUS (EUS-guided cholangiopancreatography) | Alternative when ERCP fails — EUS-guided puncture of bile duct from duodenum/stomach → guidewire → stent [7] |
Phase 2: Long-Term / Definitive Management
Once the acute episode is controlled, the focus shifts to breaking the vicious cycle and preventing long-term complications (cirrhosis, cholangiocarcinoma).
| Strategy | Detail | Rationale |
|---|---|---|
| USG surveillance | Regular interval ultrasound (e.g., every 6–12 months) [2] | Monitor for stone recurrence, new strictures, hepatic atrophy, suspicious masses (cholangioCA) |
| Interval ERCP | Scheduled ERCP sessions to remove stones and dilate strictures [2] | Reduces stone burden and relieves obstruction — breaks the stasis → infection → stone cycle |
| Percutaneous choledochoscopy | Through a mature PTBD or HCJ tract → direct visualisation and stone extraction | Allows repeated access to intrahepatic ducts for clearance without repeated ERCP |
B. Hepatobiliary Resection + Biliary-Enteric Anastomosis (Definitive Surgery)
This is the cornerstone of definitive management for RPC when disease is localised and the non-operative approach fails or complications arise [1][2].
| Indication | Rationale |
|---|---|
| Atrophic liver segment | The segment is non-functional, harbours stones and strictures, and serves as a persistent source of infection. Removing it eliminates the diseased reservoir [2] |
| Failed non-operative treatment | Recurrent cholangitis despite regular ERCP/PTBD stone clearance → the strictures and stones are too extensive for endoscopic management alone [2] |
| Suspected cholangiocarcinoma | Chronic inflammation → dysplasia → carcinoma. Resection is both diagnostic and therapeutic — removes the at-risk tissue [2] |
a) Hepatobiliary Resection [1]
- Resection of the hepatobiliary segments with the aim to resect areas of recurrent infection, biliary stasis and hepatic atrophy [1]
- Typically involves left hepatectomy (or left lateral sectionectomy) given the left lobe predilection of RPC
- May involve segmentectomy if disease is more localised
- Removes the entire diseased segment — strictures, stones, atrophic parenchyma, and potential pre-malignant tissue
b) Biliary-Enteric Anastomosis [1]
| Procedure | Description | Role in RPC |
|---|---|---|
| Hepaticojejunostomy (HJ) | Anastomosis of the hepatic duct to a Roux-en-Y jejunal loop | Frequently required in RPC [1] — provides wide drainage of the remaining biliary tree into the jejunum, bypassing any residual extrahepatic strictures |
| Choledochoduodenostomy | Anastomosis of CBD to duodenum | Contraindicated in RPC — residual strictured biliary segments may not be drained adequately [1] |
| Choledochojejunostomy | Anastomosis of CBD to jejunum | Also contraindicated in RPC — same reason; does not address intrahepatic disease above the anastomosis [1] |
Why Hepaticojejunostomy and NOT Choledochoduodenostomy/Choledochojejunostomy?
Standard biliary drainage procedures such as choledochoduodenostomy or choledochojejunostomy are contraindicated in RPC since residual strictured biliary segments may not be drained adequately [1]. The problem in RPC is intrahepatic — connecting the CBD to the bowel does nothing for strictured intrahepatic segments above the anastomosis. Hepaticojejunostomy connects at a higher level (at the hepatic duct), and when combined with resection of the diseased segments, ensures that the remaining healthy biliary tree drains adequately.
c) Hepaticocutaneojejunostomy (HCJ) [2]
- A specialised procedure where a Roux-en-Y jejunal loop is brought to the skin (subcutaneous) as a future access loop
- Purpose: allows repeated percutaneous access for choledochoscopy and stone clearance through the subcutaneous loop without needing ERCP or reoperation
- Particularly useful in patients with diffuse bilateral disease where complete resection is not possible but ongoing stone clearance is needed
| Condition | Treatment | Rationale |
|---|---|---|
| Clonorchis sinensis infection | Praziquantel 25 mg/kg PO TDS × 1 day [3] | Eliminates the parasitic trigger that initiated and perpetuates epithelial damage → breaks the vicious cycle at its origin |
| Intervention | Rationale |
|---|---|
| Adequate protein intake | Low-protein diet was the historical risk factor → relative enzyme deficiency → promotes stone formation. Improving nutrition may reduce stone recurrence |
| Fat-soluble vitamin supplementation (A, D, E, K) | Chronic biliary obstruction → malabsorption of fat-soluble vitamins. Vitamin K specifically to prevent coagulopathy |
| Phase | Priorities | Key Interventions |
|---|---|---|
| Acute (RAD) | Control sepsis, relieve obstruction | Resuscitation (NPO, IV fluids, monitoring); Antibiotics (Augmentin/Tazocin/Cefuroxime+Metro); Drainage (ERCP → PTBD → ECBD) [6][7] |
| Subacute (post-sepsis) | Complete stone clearance, map disease extent | Interval ERCP for stone removal; CT/MRCP for surgical planning; stool O&P; anti-parasitic Rx |
| Long-term (definitive) | Break the vicious cycle, prevent complications | Regular ductal clearance (USG surveillance + ERCP) [2]; Hepatobiliary resection + HJ if indicated [1][2]; anti-parasitic treatment |
| Surveillance | Detect cholangiocarcinoma early | Regular USG; serial CA 19-9 if indicated; low threshold for CT/MRI if new symptoms |
Special Considerations
During the acute phase, continuously monitor for signs that conservative treatment is failing:
| Sign | Implication |
|---|---|
| ↑ Temperature / Pulse | Worsening sepsis |
| ↓ BP / Consciousness / Urine output | Progression to septic shock (Reynold's pentad) |
| Increased abdominal tenderness and guarding | Potential biliary perforation, peritonitis, or liver abscess formation |
Definitive treatment should be deferred until cholangitis has been treated and the proper diagnosis is established [6]. Never rush to definitive surgery during acute sepsis — stabilise first.
| Complication | Presentation | Management |
|---|---|---|
| Post-ERCP fever and tachycardia | DDx: persistent cholangitis (unsuccessful drainage, migrated/blocked stent, resistant organisms), flare-up sepsis, pancreatitis, perforation [15] | AXR (stent position), repeat imaging, consider re-intervention |
| Post-ERCP abdominal pain | DDx: post-ERCP pancreatitis (elevated amylase/lipase), perforation | CT abdomen (retroperitoneal free gas) [15]; conservative vs surgical management depending on type |
| Issue | Detail |
|---|---|
| Stent occlusion | Sludge, biofilm, tumour ingrowth (metallic stents) → recurrent cholangitis → requires stent exchange |
| Stent migration | Stent displaces distally into duodenum or proximally into duct → loss of drainage → recurrent symptoms |
| Patients with indwelling stents and cholangitis | Usually require repeated imaging and stent removal and replacement [6] |
| Feature | ERCP | PTBD | ECBD (Surgical) |
|---|---|---|---|
| Access | Retrograde (from duodenum) | Antegrade (percutaneous through liver) | Direct (open abdomen) |
| Best for | CBD/extrahepatic stones | Intrahepatic obstruction (above confluence) | Failure of both ERCP and PTBD |
| Therapeutic capability | Sphincterotomy, stone removal, stent | Drainage, stent, stone removal | Complete exploration + T-tube |
| RPC-specific limitation | Difficult intrahepatic access [1][2] | Requires dilated ducts for safe puncture | High mortality (~30%) [7] |
| Relative C/I | Altered GI anatomy (Billroth II, Roux-en-Y) [15] | Coagulopathy, ascites, non-dilated ducts | Haemodynamic instability |
| Mortality | < 5% [7] | Similar to ERCP [7] | ~30% [7] |
To truly understand why this management works, recall the pathophysiology from the lecture slides [16]:
Normal ductal pressure: 7–14 cm H₂O. Increased biliary pressure > 25 cm H₂O → bacteria reflux to hepatic veins and lymphatics → bacteraemia and septic shock. Excretion of antibiotics impaired in biliary obstruction. Biliary drainage is mandatory. [16]
This explains everything:
- Why antibiotics alone fail: They cannot be excreted into bile when the ducts are obstructed → cannot achieve therapeutic concentrations at the site of infection
- Why drainage is mandatory: Must physically reduce biliary pressure below 25 cm H₂O → stops bacterial reflux into the bloodstream → allows antibiotics to work
- Why decompression is urgent in Reynold's pentad: The patient already has bacteraemia and septic shock → every hour of delay worsens outcomes
High Yield Summary — Management of RPC
-
Acute management = RAD: Resuscitation (NPO, IV fluids, monitor Q1h) → Antibiotics (Augmentin for mild / Tazocin for severe / Cefuroxime + Metronidazole × 7 days) → Drainage (urgent if Reynold's pentad or no response to antibiotics in 24h)
-
QMH drainage escalation: ERCP → PTBD → ECBD (surgical exploration has ~30% mortality — last resort)
-
ERCP role in acute setting: Biliary drainage and decompression — NOT stone removal. Aspirate pus/bile first, then contrast, then plastic stent
-
PTBD preferred when intrahepatic obstruction — directly accesses intrahepatic ducts that ERCP cannot reach
-
Biliary drainage is mandatory because antibiotic excretion is impaired in biliary obstruction and biliary pressure > 25 cm H₂O causes bacteraemia
-
15% of patients will NOT respond to antibiotics → need emergency drainage
-
Definitive surgery: Hepatobiliary resection + hepaticojejunostomy — indications: atrophic segment, failed non-op Tx, suspected cholangioCA
-
Choledochoduodenostomy and choledochojejunostomy are CONTRAINDICATED in RPC because residual strictured segments are not drained adequately
-
Definitive treatment deferred until cholangitis resolved — never operate on a septic patient for definitive surgery
-
Anti-parasitic: Praziquantel 25 mg/kg TDS × 1 day for Clonorchis sinensis
-
Long-term: Regular ductal clearance (USG surveillance + interval ERCP); HCJ for repeated percutaneous access
Active Recall - Management of RPC
[1] Senior notes: felixlai.md (Recurrent pyogenic cholangitis — Treatment section, pp. 527–528) [2] Senior notes: maxim.md (Recurrent pyogenic cholangitis — Management section, pp. 136–137) [3] Senior notes: maxim.md (Clonorchis sinensis infection — Treatment, p. 138) [6] Senior notes: felixlai.md (Acute cholangitis — Treatment section, pp. 522–525) [7] Senior notes: maxim.md (Acute cholangitis — Acute management RAD, pp. 135–136) [14] Senior notes: felixlai.md (MBO — PTBD section, pp. 504–505) [15] Lecture slides: GC 200. RUQ pain, jaundice and fever Cholecytitis and cholangitis Imaging of GI system.pdf (pp. 13–15, Acute cholangitis management, ERCP, surgical treatment) [16] Lecture slides: Malignant biliary obstruction.pdf (pp. 15–17, Cholangitis pathophysiology, biliary pressure, antibiotic excretion, management principles)
The complications of RPC can be understood as the downstream consequences of the disease's vicious cycle — stasis, stricturing, and recurrent infection — playing out across different timescales. Some complications are acute (from each cholangitis flare), some are chronic (from cumulative damage over years), and one is neoplastic (the dreaded end-stage transformation). Additionally, there are complications arising from the treatment itself (iatrogenic) [1][2][17].
A helpful way to organise these is by category and by timeline:
A. Acute Complications
These arise during or shortly after each cholangitis flare. They are direct consequences of acute biliary obstruction + bacterial infection.
| Aspect | Detail |
|---|---|
| Definition | Systemic infection originating from the infected biliary tree — bacteraemia progressing to sepsis and septic shock [1][2][17] |
| Mechanism | Biliary obstruction → biliary pressure rises above 25 cm H₂O → bacteria reflux into hepatic veins and lymphatics → bacteraemia and septic shock [16]. The obstructed biliary system becomes a pressurised reservoir of infected bile. Gram-negative endotoxin enters the systemic circulation → activates complement, coagulation cascades, and inflammatory mediators (TNF-α, IL-1, IL-6) → SIRS → sepsis → multiorgan dysfunction |
| Clinical presentation | Reynold's pentad: Charcot's triad (fever + RUQ pain + jaundice) + shock (hypotension) + altered mental status (confusion) [6]. Present in < 10% of patients but carries very high mortality |
| Why it's dangerous | Excretion of antibiotics is impaired in biliary obstruction [16] — even appropriate antibiotics cannot reach adequate biliary concentrations. Without drainage, antibiotics alone cannot control the infection |
| Management | Urgent biliary drainage is mandatory [16] — ERCP (first-line) → PTBD → ECBD. Aggressive resuscitation, vasopressors if needed, broad-spectrum IV antibiotics |
Biliary Sepsis — The Most Feared Acute Complication
Biliary sepsis is the leading cause of acute mortality in RPC. The combination of an obstructed, pressurised biliary system and polymicrobial infection creates a perfect storm for overwhelming sepsis. 15% of patients will NOT respond to antibiotics [6] and require emergency drainage. Any RPC patient with Reynold's pentad should be treated as a surgical emergency.
| Aspect | Detail |
|---|---|
| Definition | Localised collection of pus within the hepatic parenchyma, arising from ascending biliary infection [8][17] |
| Mechanism | Infected bile under pressure → bacteria track along intrahepatic biliary radicles → penetrate into adjacent liver parenchyma → walled-off pus collection. Ascending biliary infection accounts for 20–30% of pyogenic liver abscesses [8], and RPC is a major cause in Southeast Asia |
| Common organisms | E. coli, Klebsiella pneumoniae (common in > 60 years + DM), Streptococcus milleri [8] |
| Clinical features | Swinging fever, chills and rigors, septic-looking; tender hepatomegaly; jaundice is not as prominent as in cholangitis alone (the abscess is primarily a parenchymal problem) [8] |
| Diagnosis | USG: hypoechoic/complex cystic mass, no vascularity. CT abdomen with contrast: double-target sign (rim-enhancing with central hypodensity), cluster sign [8]. Blood culture, CRP for monitoring |
| Can be distant | Abscess formation at distant sites including lungs and brain [17] — haematogenous seeding from bacteraemia. If the patient develops neurological symptoms or respiratory deterioration during an RPC flare, think of metastatic abscess |
| Management | IV antibiotics (Augmentin or ceftriaxone + metronidazole for ≥ 4–6 weeks [8]); percutaneous drainage (needle aspiration if < 5 cm, catheter if > 5 cm) [8]; address the underlying biliary obstruction |
Liver Abscess vs Acute Cholangitis — They Often Coexist
In RPC, liver abscess and acute cholangitis frequently coexist. Always perform USG/CT to rule out liver abscess when treating an RPC flare [1][7]. The management of the abscess (percutaneous drainage + prolonged antibiotics) is in addition to biliary drainage for the cholangitis — missing one while treating the other leads to treatment failure.
| Aspect | Detail |
|---|---|
| Definition | Acute pancreatitis triggered by biliary stones/sludge impacting at the ampulla of Vater [2][17] |
| Mechanism | Stone or sludge from the intrahepatic/extrahepatic ducts migrates distally → impacts at the ampulla → obstructs the pancreatic duct → premature activation of pancreatic enzymes (trypsinogen → trypsin) within the pancreatic parenchyma → autodigestion → acute pancreatitis |
| Why it occurs in RPC | Result of passage of biliary stones [17]. Although RPC stones primarily form in intrahepatic ducts, fragments or sludge can migrate down into the CBD and impact at the ampulla. The disrupted sphincter from prior ERCPs also facilitates stone passage |
| Clinical features | Severe epigastric pain radiating to the back, nausea/vomiting, markedly elevated amylase/lipase ( > 3× ULN) |
| Management | Supportive (NPO, IV fluids, analgesia); early ERCP if concurrent cholangitis; address the underlying biliary pathology |
| Aspect | Detail |
|---|---|
| Definition | Rupture of obstructed pus-filled bile ducts into the peritoneum [17] |
| Mechanism | Severe obstruction → biliary pressure rises markedly → the wall of a pus-filled, dilated bile duct becomes necrotic from infection and ischaemia → perforation → infected bile and pus leak into the peritoneal cavity → biliary peritonitis |
| Clinical features | Sudden worsening of abdominal pain, generalised tenderness, guarding, board-like rigidity (peritonism), septic shock |
| Diagnosis | CT: free fluid in peritoneal cavity, discontinuity of bile duct wall |
| Management | Surgical emergency — peritoneal lavage + biliary drainage + antibiotics |
This is a rare but catastrophic complication. The bile duct is essentially a pressurised tube of pus, and when it bursts, it contaminates the entire peritoneal cavity.
B. Chronic / Progressive Complications
These develop insidiously over years from the cumulative effect of repeated obstruction, infection, and inflammation.
| Aspect | Detail |
|---|---|
| Definition | Cirrhosis (irreversible fibrosis with regenerative nodules) resulting from chronic, prolonged biliary obstruction [2][17] |
| Mechanism | Chronic biliary obstruction → persistent cholestasis → bile acids accumulate in hepatocytes → hepatocyte injury → periductal fibrosis → bridging fibrosis → cirrhosis. The bile acids are detergent molecules — when they cannot be excreted, they damage the hepatocyte membranes from within. Additionally, recurrent cholangitis episodes cause periductal inflammation and fibrosis that progressively extends into the parenchyma |
| Timeline | Takes years to decades of recurrent obstruction. This is why RPC patients who present at age 30–40 may develop cirrhosis by their 50s–60s if the disease is not adequately managed |
| Consequences | Portal hypertension (varices, ascites, splenomegaly), synthetic failure (hypoalbuminaemia, coagulopathy), hepatorenal syndrome, hepatic encephalopathy |
| Clinical features | Spider naevi, palmar erythema, ascites, splenomegaly, caput medusae, jaundice (now from hepatocellular failure rather than just obstruction) |
| Key point | This is a preventable complication — adequate biliary drainage and definitive surgery (hepatic resection + HJ) can arrest progression before cirrhosis develops |
| Aspect | Detail |
|---|---|
| Definition | Volume loss of a hepatic lobe or segment due to chronic obstruction and parenchymal destruction [1][2] |
| Mechanism | Chronic obstruction of intrahepatic ducts in a particular segment → persistent cholestasis and ischaemia → hepatocyte death → parenchymal collapse → fibrotic replacement → volume loss. The contralateral lobe undergoes compensatory hypertrophy |
| Predilection | Left lobe (reflecting the left-sided predominance of RPC) [2] |
| Imaging | CT: small, atrophic left lobe with dilated ducts and stones; hypertrophied right lobe |
| Significance | An atrophic segment is non-functional, harbours infection and stones, and serves as a persistent source of sepsis. It is also at risk for malignant transformation. This is one of the key indications for hepatic resection [2] |
| Aspect | Detail |
|---|---|
| Definition | Thrombosis within the portal vein or its branches [17] |
| Mechanism | Chronic periductal inflammation from recurrent cholangitis → inflammatory damage to the portal vein (which runs alongside the bile ducts in the portal triad) → endothelial injury → activation of coagulation cascade → thrombus formation. Additionally, biliary sepsis causes a systemic pro-coagulant state (DIC, sepsis-associated coagulopathy). Hepatic atrophy and fibrosis also reduce portal flow, promoting stasis (Virchow's triad: stasis + endothelial injury + hypercoagulability — all present in RPC) |
| Consequences | Worsens portal hypertension → variceal bleeding, ascites; can cause mesenteric ischaemia if extension occurs |
| Diagnosis | Doppler ultrasound; CT with contrast (filling defect in portal vein) |
| Significance | Complicates surgical planning — portal vein thrombosis may make hepatic resection more technically challenging or preclude it |
| Aspect | Detail |
|---|---|
| Definition | End-stage hepatic decompensation [17] |
| Mechanism | Progressive biliary cirrhosis → loss of critical mass of functional hepatocytes → failure of synthetic, excretory, and detoxification functions. Additionally, recurrent sepsis causes cumulative hepatocyte damage |
| Clinical features | Jaundice (progressive, now hepatocellular), coagulopathy, hypoalbuminaemia, hepatic encephalopathy, ascites, hepatorenal syndrome |
| Management | Liver transplantation may be considered in advanced cases — though this is rarely performed for RPC specifically, as the disease is typically managed with resection and drainage before it reaches this stage |
| Aspect | Detail |
|---|---|
| Definition | Formation of choledocho-duodenal fistula into gastrointestinal tract or abdominal wall [17] |
| Mechanism | Chronic inflammation from recurrent cholangitis → erosion through the bile duct wall into adjacent structures. The continuous cycle of infection and healing weakens the duct wall and surrounding tissues. Stones themselves can erode through the wall by pressure necrosis |
| Types | Choledocho-duodenal fistula (most common — bile duct erodes into duodenum); cholecysto-enteric fistula; fistula to abdominal wall (rare) |
| Consequences | Pneumobilia/aerobilia (air in biliary tree — from the GI tract entering through the fistula); may predispose to further ascending infection; rarely, gallstone ileus if a large stone passes through the fistula into the bowel |
| Diagnosis | Imaging: aerobilia on AXR/CT; contrast studies may demonstrate the fistula tract |
10. Cholangiocarcinoma — The Most Important Long-Term Complication
This deserves special emphasis because it is the most feared long-term outcome and directly impacts surveillance strategy.
| Aspect | Detail |
|---|---|
| Definition | Malignant tumour of the bile duct epithelium — > 90% are adenocarcinoma [5][11] |
| Mechanism | Chronic inflammation → repeated epithelial injury and regeneration → accumulation of genetic mutations → dysplasia → carcinoma sequence. This is analogous to the colitis-associated cancer sequence in UC. The bile duct epithelium in RPC is subjected to decades of: (1) direct bacterial damage, (2) bile acid-induced mutagenesis (retained bile acids are genotoxic), (3) parasitic-induced chronic inflammation (Clonorchis sinensis), (4) generation of reactive oxygen species (ROS) from chronic infection |
| Epidemiological link | Association with ulcerative colitis (common in Westerners) and recurrent pyogenic cholangitis (common in Orientals) [5]. Mostly occurs in patients > 50 years [5] |
| Risk factors for cholangioCA in RPC | Duration of disease (longer → higher risk); extent of stricturing; hepatolithiasis; Clonorchis infection; PSC overlap [11] |
| Clinical red flags | New or worsening progressive painless jaundice (different from the episodic painful jaundice of RPC flares); unexplained weight loss; anorexia; rising CA 19-9 on serial measurement; new hepatomegaly; RUQ pain, hepatomegaly, jaundice [5] |
| Diagnosis | Tumour markers: CEA and CA 19-9 (may or may not be elevated, nonspecific) [5]; USG, CT scan, MRI [5]; FNAC or Trucut biopsy (ONLY for unresectable cases) [5]; choledochoscopy with biopsy for histological confirmation |
| Treatment | Hepatic resection is the treatment of choice (resectability rate about 20%) [5]; other treatment: no proven effect [5]. The low resectability rate reflects the fact that cholangiocarcinoma is often diagnosed late, especially when superimposed on RPC (the symptoms of malignancy overlap with the symptoms of RPC flares) |
| Prognosis | Very poor — especially when diagnosed late. This underscores the importance of vigilant surveillance in all RPC patients |
Why RPC → Cholangiocarcinoma — The Molecular Rationale
The chronic inflammation-to-cancer pathway in RPC involves several molecular mechanisms:
- NF-κB activation by bacterial endotoxin → chronic inflammatory signalling → promotes cell survival and proliferation
- Reactive oxygen species (ROS) from activated neutrophils and macrophages → DNA damage → oncogenic mutations
- Bile acid genotoxicity — retained bile acids (especially secondary bile acids) cause direct DNA damage and promote apoptosis resistance
- IL-6/STAT3 signalling — upregulated in chronic cholangitis → drives cholangiocyte proliferation and survival
- Parasite-specific factors — Clonorchis sinensis secretes excretory/secretory products that directly promote cell proliferation via the Wnt/β-catenin pathway
The cumulative effect over decades is a field change in the biliary epithelium — widespread dysplasia from which carcinoma eventually emerges.
Screening and Surveillance for Cholangiocarcinoma in RPC
There is no universally standardised surveillance protocol, but the following approach is widely practiced in Hong Kong centres:
- Regular USG (every 6–12 months) — look for new masses, worsening strictures, change in biliary anatomy
- Serial CA 19-9 — a rising trend (even if absolute value is within normal range) should prompt further investigation
- Low threshold for CT/MRI if any clinical change (new weight loss, worsening jaundice, failure to respond to usual treatment)
- Choledochoscopy with biopsy during any planned ERCP/PTBD procedure — direct visualisation and tissue sampling
- FNAC or Trucut biopsy should be performed ONLY for unresectable cases [5] — in potentially resectable tumours, percutaneous biopsy risks needle-tract seeding
D. Iatrogenic / Treatment-Related Complications
RPC patients undergo frequent invasive procedures (ERCP, PTBD, surgery), each carrying its own complication profile.
| Complication | Mechanism | Features | Management |
|---|---|---|---|
| Acute pancreatitis | Instrumentation near pancreatic duct orifice → traumatic oedema → pancreatic duct obstruction → enzyme activation | Epigastric pain post-procedure; elevated amylase/lipase | Conservative (NPO, IV fluids); usually self-limited |
| Perforation [6][15] | Sphincterotomy cuts through duodenal wall or bile duct wall | Intraperitoneal: free gas under diaphragm → requires surgery (will not seal). Retroperitoneal: no free gas under diaphragm, retroperitoneal gas → conservative treatment (will seal spontaneously) [6] | Surgery vs conservative based on type |
| Bleeding from papillotomy [15] | Electrocautery damages vessels at the sphincter during sphincterotomy | Haematemesis, melaena, haemobilia | Endoscopic haemostasis (adrenaline injection, cautery, clips); correct coagulopathy |
| Cholangitis flare | Instrumentation introduces organisms; incomplete drainage; stent occlusion | Fever, tachycardia post-ERCP | Check stent position (AXR); repeat drainage if needed; antibiotics |
| Stent occlusion/migration | Sludge/biofilm (plastic stents); tumour ingrowth (metallic stents); mechanical displacement | Recurrent jaundice, cholangitis | Stent exchange at scheduled intervals |
| Complication | Mechanism |
|---|---|
| Bacteraemia | Needle traverses infected parenchyma → organisms enter bloodstream. Antibiotic prophylaxis required [14] |
| Haemobilia | Needle punctures a branch of the hepatic artery or portal vein (they travel together in the portal triad) → blood enters bile duct → haemobilia (blood in bile) |
| Fluid and electrolyte loss | External bile drainage → loss of bile salts, bicarbonate, and fluid → dehydration, electrolyte imbalance, malabsorption |
| Bile leak / peritonitis | Catheter dislodgement or tract disruption → bile leaks into peritoneal cavity |
| Pneumothorax | Right-sided approach may transgress the pleural space (the right intrahepatic approach is intercostal). This is why left hepatic duct access is preferred (subcostal, less painful, avoids pleura) [6] |
| Complication | Mechanism |
|---|---|
| Anastomotic stricture | Fibrosis at the hepaticojejunostomy site → recurrent biliary obstruction → cholangitis. The most frequent long-term complication of Roux-en-Y hepaticojejunostomy is stenosis of the biliary-enteric anastomosis leading to jaundice, cirrhosis, or cholangitis [18] |
| Bile leak | Anastomotic leak or cut surface leak → biloma → infection |
| Liver failure (post-resection) | Insufficient future liver remnant after hepatic resection → post-hepatectomy liver failure |
| Recurrent stone formation | Even after resection, remaining ducts may develop new stones if the underlying stasis-infection cycle is not completely broken |
| Wound infection / poor wound healing | Cholestasis → impaired protein synthesis → impaired wound healing; nutritional deficiency; immunosuppression from sepsis |
| Timeline | Complications |
|---|---|
| Acute (each flare) | Biliary sepsis, liver abscess (local and distant — lungs, brain), pancreatitis, rupture of bile ducts |
| Chronic (years) | Secondary biliary cirrhosis, hepatic atrophy, portal vein thrombosis, liver failure, fistulisation |
| Neoplastic (decades) | Cholangiocarcinoma — the most important long-term complication |
| Iatrogenic | Post-ERCP (pancreatitis, perforation, bleeding, cholangitis), post-PTBD (haemobilia, bacteraemia), post-surgical (anastomotic stricture, bile leak, liver failure) |
High Yield Summary — Complications of RPC
-
Acute complications arise from each cholangitis flare: biliary sepsis (Reynold's pentad — urgent drainage mandatory), liver abscess (ascending biliary infection; swinging fever, tender hepatomegaly; double-target sign on CT), pancreatitis (stone passage to ampulla), rupture of pus-filled bile ducts into peritoneum
-
Chronic complications arise from cumulative damage: secondary biliary cirrhosis (chronic cholestasis → fibrosis), hepatic atrophy (left lobe predominant; indication for resection), portal vein thrombosis (periductal inflammation + hypercoagulability), liver failure (end-stage), fistulisation (erosion into bowel/abdominal wall)
-
Cholangiocarcinoma is the most important long-term neoplastic complication — driven by chronic inflammation → dysplasia → carcinoma sequence. Associated with RPC in Orientals and PSC/UC in Westerners [5]. Hepatic resection is the treatment of choice (resectability rate ~20%) [5]. FNAC/biopsy ONLY for unresectable cases [5]
-
Iatrogenic complications: Post-ERCP (pancreatitis, perforation — distinguish intraperitoneal from retroperitoneal, bleeding); Post-PTBD (haemobilia, bacteraemia); Post-surgery (anastomotic stricture — most common long-term surgical complication)
-
Key management principles: Biliary drainage is mandatory for acute sepsis; percutaneous drainage for liver abscess; hepatic resection for atrophic segments and suspected cholangioCA; regular surveillance for malignancy
Active Recall - Complications of RPC
[1] Senior notes: felixlai.md (Recurrent pyogenic cholangitis — Complications section, p. 528) [2] Senior notes: maxim.md (Recurrent pyogenic cholangitis — Complications, pp. 136–137) [3] Senior notes: maxim.md (Clonorchis sinensis infection, p. 138) [5] Lecture slides: WCS 064 - A large liver - by Prof R Poon [20191108].doc.pdf (p. 5, Cholangiocarcinoma — aetiology, diagnosis, treatment) [6] Senior notes: felixlai.md (Acute cholangitis — Treatment and ERCP complications, pp. 522–525) [7] Senior notes: maxim.md (Acute cholangitis — Acute management RAD, pp. 135–136) [8] Senior notes: maxim.md (Liver abscess section, p. 125) [11] Senior notes: felixlai.md (Cholangiocarcinoma — Etiology and risk factors, pp. 547–548) [14] Senior notes: felixlai.md (PTBD section, pp. 504–505, 524) [15] Lecture slides: GC 200. RUQ pain, jaundice and fever Cholecytitis and cholangitis Imaging of GI system.pdf (p. 14, ERCP complications) [16] Lecture slides: Malignant biliary obstruction.pdf (p. 16, Cholangitis — biliary pressure, antibiotic excretion, drainage mandatory) [17] Senior notes: felixlai.md (RPC — Complications, p. 528) [18] Senior notes: felixlai.md (Biliary cysts — Complications of Roux-en-Y HJ, p. 544)
High Yield Summary
-
Definition: RPC = recurrent bacterial cholangitis + intrahepatic pigment stone formation + intrahepatic biliary strictures; also called "Hong Kong disease"
-
Epidemiology: Southeast Asia, equal M:F, peak 30–40 years
-
Pathophysiology — Vicious Cycle: Parasitic/bacterial damage → strictures → stasis → bacterial β-glucuronidase deconjugates bilirubin → Ca bilirubinate (brown pigment) stones → further obstruction → recurrent infection
-
Key Differences from Western Gallstone Disease: Stones form de novo in intrahepatic ducts (not gallbladder); composed of brown pigment (not cholesterol); radio-opaque (not radiolucent)
-
Left lobe predilection — due to anatomical factors promoting stasis
-
Clinical Features: Charcot's triad (fever + RUQ pain + jaundice); 1–2 episodes/year; Reynold's pentad if severe sepsis
-
Exception to Courvoisier's Law: Gallbladder NOT fibrosed (pathology is in ducts) → CAN distend
-
Clonorchis sinensis: Chinese liver fluke, transmitted by raw freshwater fish, initiates epithelial damage; treated with praziquantel
-
Major Long-term Complications: Secondary biliary cirrhosis, hepatic atrophy, cholangiocarcinoma
-
Organisms: E. coli, Klebsiella, Pseudomonas (gram-negatives); anaerobes; Enterococcus
High Yield Summary — Differential Diagnosis
-
Most important DDx: Choledocholithiasis with acute cholangitis — differentiate by stone location (CBD vs intrahepatic), stone type (cholesterol vs pigment), presence of strictures, and recurrence pattern
-
Liver abscess can mimic AND complicate RPC — look for swinging fever, tender hepatomegaly, double-target sign on CT; jaundice is NOT prominent in isolated liver abscess
-
PSC vs RPC: PSC = Western, autoimmune, UC association, large duct disease, rare in Asia. RPC = Oriental, infectious, parasitic association, small duct disease, common in Hong Kong
-
Cholangiocarcinoma is both a DDx and a complication — progressive painless jaundice + weight loss in a patient > 50; associated with UC (Westerners) and RPC (Orientals)
-
Congenital causes (Caroli's disease, choledochal cysts) present in childhood; can predispose to RPC
-
Level of obstruction guides DDx: RPC causes hilar/intrahepatic obstruction; distal obstruction → think periampullary tumours
-
Exception to Courvoisier's law: Both RPC and Mirizzi syndrome are exceptions — but the mechanism differs (RPC: gallbladder not fibrosed because pathology is in ducts; Mirizzi: stone at Hartmann's pouch compresses CHD)
High Yield Summary — Diagnosis of RPC
-
Diagnostic criteria: Use Tokyo Guidelines (TG18) for acute cholangitis — Suspected: systemic inflammation + cholestasis; Definite: + biliary dilatation + etiology on imaging
-
Severity grading matters: Grade III (organ dysfunction / Reynold's pentad) → urgent biliary drainage
-
RPC-specific imaging pattern: Intrahepatic stones + strictures + central dilatation with peripheral tapering + left lobe predilection + hepatic atrophy
-
Blood tests: Cholestatic pattern LFT (↑ ALP, GGT, conjugated bilirubin); leukocytosis; blood culture BEFORE antibiotics; clotting (Vitamin K deficiency); stool ova and parasites
-
Imaging hierarchy: USG first → CT for staging/complications → MRCP for biliary mapping → ERCP for therapeutic drainage
-
MRCP does NOT permit therapeutic interventions — use it for mapping, not treatment
-
ERCP prophylactic antibiotics required due to risk of inciting cholangitis
-
PTBD preferred over ERCP when obstruction at or above hepatic duct confluence — directly accesses intrahepatic disease
-
QMH practice: ERCP → PTBD → ECBD (stepwise escalation)
-
Tumour markers (CEA, CA 19-9) are NOT useful for screening — absence does not exclude malignancy; useful for serial monitoring post-resection
High Yield Summary — Management of RPC
-
Acute management = RAD: Resuscitation (NPO, IV fluids, monitor Q1h) → Antibiotics (Augmentin for mild / Tazocin for severe / Cefuroxime + Metronidazole × 7 days) → Drainage (urgent if Reynold's pentad or no response to antibiotics in 24h)
-
QMH drainage escalation: ERCP → PTBD → ECBD (surgical exploration has ~30% mortality — last resort)
-
ERCP role in acute setting: Biliary drainage and decompression — NOT stone removal. Aspirate pus/bile first, then contrast, then plastic stent
-
PTBD preferred when intrahepatic obstruction — directly accesses intrahepatic ducts that ERCP cannot reach
-
Biliary drainage is mandatory because antibiotic excretion is impaired in biliary obstruction and biliary pressure > 25 cm H₂O causes bacteraemia
-
15% of patients will NOT respond to antibiotics → need emergency drainage
-
Definitive surgery: Hepatobiliary resection + hepaticojejunostomy — indications: atrophic segment, failed non-op Tx, suspected cholangioCA
-
Choledochoduodenostomy and choledochojejunostomy are CONTRAINDICATED in RPC because residual strictured segments are not drained adequately
-
Definitive treatment deferred until cholangitis resolved — never operate on a septic patient for definitive surgery
-
Anti-parasitic: Praziquantel 25 mg/kg TDS × 1 day for Clonorchis sinensis
-
Long-term: Regular ductal clearance (USG surveillance + interval ERCP); HCJ for repeated percutaneous access
High Yield Summary — Complications of RPC
-
Acute complications arise from each cholangitis flare: biliary sepsis (Reynold's pentad — urgent drainage mandatory), liver abscess (ascending biliary infection; swinging fever, tender hepatomegaly; double-target sign on CT), pancreatitis (stone passage to ampulla), rupture of pus-filled bile ducts into peritoneum
-
Chronic complications arise from cumulative damage: secondary biliary cirrhosis (chronic cholestasis → fibrosis), hepatic atrophy (left lobe predominant; indication for resection), portal vein thrombosis (periductal inflammation + hypercoagulability), liver failure (end-stage), fistulisation (erosion into bowel/abdominal wall)
-
Cholangiocarcinoma is the most important long-term neoplastic complication — driven by chronic inflammation → dysplasia → carcinoma sequence. Associated with RPC in Orientals and PSC/UC in Westerners [5]. Hepatic resection is the treatment of choice (resectability rate ~20%) [5]. FNAC/biopsy ONLY for unresectable cases [5]
-
Iatrogenic complications: Post-ERCP (pancreatitis, perforation — distinguish intraperitoneal from retroperitoneal, bleeding); Post-PTBD (haemobilia, bacteraemia); Post-surgery (anastomotic stricture — most common long-term surgical complication)
-
Key management principles: Biliary drainage is mandatory for acute sepsis; percutaneous drainage for liver abscess; hepatic resection for atrophic segments and suspected cholangioCA; regular surveillance for malignancy
Primary Sclerosing Cholangitis
Primary sclerosing cholangitis is a chronic cholestatic liver disease characterized by progressive inflammation, fibrosis, and stricturing of the intrahepatic and extrahepatic bile ducts, often associated with inflammatory bowel disease.
Benign Breast Disease
Benign breast disease encompasses a spectrum of non-cancerous breast conditions—including fibrocystic changes, fibroadenomas, and intraductal papillomas—that may present with pain, lumps, or nipple discharge and vary in their associated risk of subsequent malignancy.